<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v3.0 20080202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing3.dtd?><?SourceDTD.Version 3.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Pathog</journal-id><journal-id journal-id-type="iso-abbrev">PLoS Pathog</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plospath</journal-id><journal-title-group><journal-title>PLoS Pathogens</journal-title></journal-title-group><issn pub-type="ppub">1553-7366</issn><issn pub-type="epub">1553-7374</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4310594</article-id><article-id pub-id-type="pmid">25633080</article-id><article-id pub-id-type="publisher-id">PPATHOGENS-D-14-01080</article-id><article-id pub-id-type="doi">10.1371/journal.ppat.1004627</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Elucidation of the RamA Regulon in <italic>Klebsiella pneumoniae</italic> Reveals a Role in LPS Regulation</article-title><alt-title alt-title-type="running-head">RamA Regulon in <italic>K. pneumoniae</italic></alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>De Majumdar</surname><given-names>Shyamasree</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Yu</surname><given-names>Jing</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Fookes</surname><given-names>Maria</given-names></name><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>McAteer</surname><given-names>Sean P.</given-names></name><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Llobet</surname><given-names>Enrique</given-names></name><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Finn</surname><given-names>Sarah</given-names></name><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Spence</surname><given-names>Shaun</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Monaghan</surname><given-names>Avril</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kissenpfennig</surname><given-names>Adrien</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ingram</surname><given-names>Rebecca J.</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bengoechea</surname><given-names>Jos&#x000e9;</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gally</surname><given-names>David L.</given-names></name><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Fanning</surname><given-names>S&#x000e9;amus</given-names></name><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Elborn</surname><given-names>Joseph S.</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Schneiders</surname><given-names>Thamarai</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label><addr-line>Centre for Infection and Immunity, Belfast, United Kingdom</addr-line></aff><aff id="aff002"><label>2</label><addr-line>Division of Pathway and Infection Medicine, Edinburgh, United Kingdom</addr-line></aff><aff id="aff003"><label>3</label><addr-line>Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom</addr-line></aff><aff id="aff004"><label>4</label><addr-line>Division of Immunity and Infection, The Roslin Institute and R(D)SVS, The University of Edinburgh, Easter Bush, Midlothian, United Kingdom</addr-line></aff><aff id="aff005"><label>5</label><addr-line>Laboratory Microbial Pathogenesis, Fundaci&#x000f3; d&#x02019;Investigaci&#x000f3; Sanit&#x000e0;ria de les Illes Balears (FISIB) Recinto Hospital Joan March, Bunyola, Spain</addr-line></aff><aff id="aff006"><label>6</label><addr-line>UCD Centre for Molecular Innovation and Drug Discovery, School of Public Health, Physiotherapy &#x00026; Population Science, University College Dublin, Dublin, Ireland</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Hauser</surname><given-names>Alan</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Northwestern University, UNITED STATES</addr-line></aff><author-notes><fn fn-type="conflict" id="coi001"><p>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con" id="contrib001"><p>Conceived and designed the experiments: SDM JY TS. Performed the experiments: SDM JY MF SPM EL SFi AM. Analyzed the data: SDM JY MF SFi RJI JB TS. Contributed reagents/materials/analysis tools: SDM JY SPM MF EL SFi SS AM AK RJI JB DLG SFa JSE TS. Wrote the paper: SDM JY MF TS.</p></fn><corresp id="cor001">* E-mail: <email>thamarai.schneiders@ed.ac.uk</email></corresp></author-notes><pub-date pub-type="collection"><month>1</month><year>2015</year></pub-date><pub-date pub-type="epub"><day>29</day><month>1</month><year>2015</year></pub-date><volume>11</volume><issue>1</issue><elocation-id>e1004627</elocation-id><history><date date-type="received"><day>15</day><month>5</month><year>2014</year></date><date date-type="accepted"><day>14</day><month>12</month><year>2014</year></date></history><permissions><copyright-year>2015</copyright-year><copyright-holder>De Majumdar et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="ppat.1004627.pdf"/><abstract><p><italic>Klebsiella pneumoniae</italic> is a significant human pathogen, in part due to high rates of multidrug resistance. RamA is an intrinsic regulator in <italic>K. pneumoniae</italic> established to be important for the bacterial response to antimicrobial challenge; however, little is known about its possible wider regulatory role in this organism during infection. In this work, we demonstrate that RamA is a global transcriptional regulator that significantly perturbs the transcriptional landscape of <italic>K. pneumoniae</italic>, resulting in altered microbe-drug or microbe-host response. This is largely due to the direct regulation of 68 genes associated with a myriad of cellular functions. Importantly, RamA directly binds and activates the <italic>lpxC</italic>, <italic>lpxL-2</italic> and <italic>lpxO</italic> genes associated with lipid A biosynthesis, thus resulting in modifications within the lipid A moiety of the lipopolysaccharide. RamA-mediated alterations decrease susceptibility to colistin E, polymyxin B and human cationic antimicrobial peptide LL-37. Increased RamA levels reduce <italic>K. pneumoniae</italic> adhesion and uptake into macrophages, which is supported by <italic>in vivo</italic> infection studies, that demonstrate increased systemic dissemination of ramA overexpressing <italic>K. pneumoniae</italic>. These data establish that RamA-mediated regulation directly perturbs microbial surface properties, including lipid A biosynthesis, which facilitate evasion from the innate host response. This highlights RamA as a global regulator that confers pathoadaptive phenotypes with implications for our understanding of the pathogenesis of <italic>Enterobacter</italic>, <italic>Salmonella</italic> and <italic>Citrobacter</italic> spp. that express orthologous RamA proteins.</p></abstract><abstract abstract-type="summary"><title>Author Summary</title><p>Bacteria can rapidly evolve under antibiotic pressure to develop resistance, which occurs when target genes mutate, or when resistance-encoding genes are transferred. Alternatively, microbes can simply alter the levels of intrinsic proteins that allow the organism to &#x0201c;buy&#x0201d; time to resist antibiotic pressure. <italic>Klebsiella pneumoniae</italic> is a pathogen that causes significant blood stream or respiratory infections, but more importantly is a bacterium that is increasingly being reported as multidrug resistant. Our data demonstrate that RamA can trigger changes on the bacterial surface that allow <italic>Klebsiella</italic> to survive both antibiotic challenge, degradation by host immune peptides and resist phagocytosis. We demonstrate that the molecular basis of increased survival of <italic>ramA</italic> overexpressing <italic>K. pneumoniae</italic>, against host-derived factors is associated with RamA-driven alterations of the lipid A moiety of <italic>Klebsiella</italic> LPS. This modification is likely to be linked to <italic>Klebsiella&#x02019;s</italic> ability to resist the host response so that it remains undetected by the immune system. The relevance of our work extends beyond RamA in <italic>Klebsiella</italic> as other pathogens such as <italic>Enterobacter</italic> spp and <italic>Salmonella</italic> spp. also produce this protein. Thus our overarching conclusion is that the intrinsic regulator, RamA perturbs host-microbe and microbe-drug interactions.</p></abstract><funding-group><funding-statement>This work was supported by grants awarded to TS from the MRC New Investigator Grant G0601199, QUB start up funds, the ESCMID Research Grant Award and the Wellcome Trust grant 098051. DLG and SPM are supported by an Institute Strategic Programme Grant from the BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="8"/><table-count count="1"/><page-count count="22"/></counts></article-meta></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>The microbial response to antimicrobial challenge is multifactorial and can be conferred by a combination of extrinsic or intrinsic mechanisms. Those intrinsic mechanisms that confer pleiotropic phenotypes can provide a &#x0201c;stepping stone&#x0201d; to surmounting both the host or drug response. Intrinsic proteins such as the AraC-transcriptional proteins e.g. MarA [<xref rid="ppat.1004627.ref001" ref-type="bibr">1</xref>], SoxS [<xref rid="ppat.1004627.ref002" ref-type="bibr">2</xref>], Rob [<xref rid="ppat.1004627.ref003" ref-type="bibr">3</xref>], RamA [<xref rid="ppat.1004627.ref004" ref-type="bibr">4</xref>] and RarA [<xref rid="ppat.1004627.ref005" ref-type="bibr">5</xref>], directly regulate genes linked to microbial permeability barriers which results in reduced susceptibility [<xref rid="ppat.1004627.ref006" ref-type="bibr">6</xref>] to multiple antibiotic classes. The perturbation of the permeability barrier is identified as a critical step in the development and emergence of higher levels of resistance [<xref rid="ppat.1004627.ref007" ref-type="bibr">7</xref>].</p><p>The regulatory proteins, typified by the MarA protein, are unique, as unlike other members of the AraC family, these proteins bind DNA as monomers [<xref rid="ppat.1004627.ref008" ref-type="bibr">8</xref>], interact with RNA polymerase via a process of pre-recruitment [<xref rid="ppat.1004627.ref009" ref-type="bibr">9</xref>] and generally confer reduced antimicrobial susceptibility [<xref rid="ppat.1004627.ref010" ref-type="bibr">10</xref>]. Microarray analyses has highlighted the wider effects of increased MarA [<xref rid="ppat.1004627.ref001" ref-type="bibr">1</xref>], SoxS [<xref rid="ppat.1004627.ref002" ref-type="bibr">2</xref>], RamA [<xref rid="ppat.1004627.ref004" ref-type="bibr">4</xref>, <xref rid="ppat.1004627.ref011" ref-type="bibr">11</xref>] and RarA [<xref rid="ppat.1004627.ref005" ref-type="bibr">5</xref>] levels in modulating gene expression particularly of those genes linked to virulence. This is further supported by studies reporting that either the inhibition or deletion of these regulators [<xref rid="ppat.1004627.ref012" ref-type="bibr">12</xref>] can impair the ability of <italic>E. coli</italic> to colonise and cause infection <italic>in vivo</italic> [<xref rid="ppat.1004627.ref013" ref-type="bibr">13</xref>]. Taken together, it is evident that these AraC proteins can confer bifunctional phenotypes of reduced drug susceptibility and increased virulence, which facilitate pathogen survival. These findings firstly, underscore the relative importance of these factors in microbial survival and secondly, provide a rationale for the development of &#x0201c;Anti-virulence-type&#x0201d; inhibitors against these transcription proteins.</p><p>The <italic>ramA</italic> gene which encodes the RamA protein is found in <italic>Klebsiella</italic>, <italic>Enterobacter</italic> [<xref rid="ppat.1004627.ref014" ref-type="bibr">14</xref>], <italic>Salmonella</italic> [<xref rid="ppat.1004627.ref015" ref-type="bibr">15</xref>] and <italic>Citrobacter</italic> spp [<xref rid="ppat.1004627.ref016" ref-type="bibr">16</xref>] where the genetic organisation of the <italic>ram</italic> locus is conserved in most organisms, with the exception of <italic>Salmonella enterica</italic> serovar Typhimurium (<xref ref-type="fig" rid="ppat.1004627.g001">Fig. 1</xref>) which lacks <italic>romA</italic>, a putative metallo-beta-lactamase gene. The levels of both the <italic>romA-ramA</italic> genes are repressed at the transcriptional level by the TetR-type family regulator RamR, encoded by the <italic>ramR</italic> gene, which is divergently transcribed from the <italic>romA-ramA</italic> operon. In both <italic>Klebsiella and Salmonella</italic>, an increase in <italic>ramA</italic> expression can be mediated by inactivating mutations [<xref rid="ppat.1004627.ref016" ref-type="bibr">16</xref>&#x02013;<xref rid="ppat.1004627.ref018" ref-type="bibr">18</xref>] or ligand mediated interactions [<xref rid="ppat.1004627.ref019" ref-type="bibr">19</xref>] with the cognate repressor, RamR which binds to a highly conserved inverted repeat (atgagtgn<sub>6</sub>cactcat) [<xref rid="ppat.1004627.ref020" ref-type="bibr">20</xref>] overlapping the promoter region of the <italic>romAramA</italic> operon (<xref ref-type="fig" rid="ppat.1004627.g001">Fig. 1</xref>). Mutations within the <italic>ramR</italic> gene in <italic>K. pneumoniae</italic> resulting in <italic>ramA</italic> overexpression were initially reported as a result of tigecycline exposure [<xref rid="ppat.1004627.ref017" ref-type="bibr">17</xref>, <xref rid="ppat.1004627.ref021" ref-type="bibr">21</xref>]. However, previous work evaluating clinical isolates that pre-date the use of tigecycline demonstrate that <italic>ramA</italic> overexpressing strains were already present within the nosocomial population of <italic>K. pneumoniae</italic>, suggesting a broader role for RamA mediated overexpression in antibiotic resistance [<xref rid="ppat.1004627.ref016" ref-type="bibr">16</xref>]. Interestingly, studies evaluating the prevalence of <italic>ramA</italic>-mediated overexpression in clinical isolates of <italic>K. pneumoniae</italic> and <italic>Salmonella</italic> spp. indicate that these bacteria are more likely to overexpress <italic>ramA</italic> than <italic>marA</italic> or <italic>soxS</italic>, suggesting that elevated <italic>ramA</italic> levels may be more relevant to the development of antibiotic resistance in these organisms.</p><fig id="ppat.1004627.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1004627.g001</object-id><label>Figure 1</label><caption><title>Organisation of the <italic>ram</italic> locus in <italic>Klebsiella pneumoniae / Enterobacter</italic> spp.</title><p>In <italic>K. pneumoniae romA</italic> and <italic>ramA</italic> are usually co-transcribed from the TSS depicted with *, under the control of the PI promoter. RamR can bind the inverted repeat (atgagtgn<sub>6</sub>cactcat), which in turn represses the transcription of both <italic>romA</italic> and <italic>ramA</italic>. Our analysis shows that the small regulatory RNA, sRamA5 and <italic>romA</italic> in <italic>Klebsiella pneumoniae</italic> share the TSS (depicted with *).</p></caption><graphic xlink:href="ppat.1004627.g001"/></fig><p>Several studies [<xref rid="ppat.1004627.ref004" ref-type="bibr">4</xref>, <xref rid="ppat.1004627.ref011" ref-type="bibr">11</xref>] have addressed the scope of the RamA regulon in <italic>Salmonella enterica</italic> serovar Typhimurium using microarray profiling. These studies demonstrate that <italic>ramA</italic> overexpression results in reduced antimicrobial susceptibility due to the differential regulation of <italic>acrAB</italic> and <italic>micF</italic> genes, which consequently decrease OmpF levels. One study [<xref rid="ppat.1004627.ref004" ref-type="bibr">4</xref>] suggests that genes linked to the Salmonella Pathogenicity Island (SPI-2) are also differentially expressed, leading to the initial observation that RamA may impact on <italic>Salmonella</italic>-specific virulence attributes. However this link was not corroborated in subsequent <italic>in vivo</italic> experiments. In <italic>K. pneumoniae</italic>, the wider impact of RamA-mediated regulation is not known. Despite the apparent similarities in genome structure, the microbial lifestyles of both <italic>K. pneumoniae</italic> [<xref rid="ppat.1004627.ref022" ref-type="bibr">22</xref>] and <italic>Salmonella</italic> spp. differ. Importantly, the increasing multidrug resistance in <italic>Klebsiella</italic> spp. demands a thorough understanding of factors within this genus that contribute to the intrinsic microbial &#x02018;resistome&#x02019; and survival under selective (host or drug) pressure. Therefore to define the broad effects of RamA-mediated expression on microbe-host and microbe-drug phenotypes we carried out transcriptome profiling using directional RNAseq with the wild type strain <italic>K. pneumoniae</italic> Ecl8 [<xref rid="ppat.1004627.ref023" ref-type="bibr">23</xref>] and its isogenic derivatives Ecl8&#x00394;<italic>ramA</italic> and Ecl8&#x00394;<italic>ramR</italic>. Our key findings show the scope of RamA-mediated regulation significantly alters the transcriptional landscape of <italic>K. pneumoniae</italic>. This occurs by directly modulating the expression of different genes notably those associated with antimicrobial resistance and host-microbe interactions thereby resulting in the emergence of a less antibiotic susceptible and more virulent <italic>K. pneumoniae</italic>.</p></sec><sec sec-type="results" id="sec002"><title>Results</title><sec id="sec002a"><title>Regulation of the <italic>ram</italic> Locus</title><p><bold>The <italic>ram</italic> locus encodes a sRNA to maintain basal levels of <italic>ramA</italic> expression</bold>. RamR functions as the primary repressor of both <italic>romA-ramA</italic> expression in <italic>K. pneumoniae</italic> by binding the palindromic repeats of the IR element which flanks the TSS for <italic>romA</italic> at position -64T. <italic>ramR</italic>, itself, has two transcriptional start sites, located at the -83T and -167A positions where expression analyses using GFP fusions suggest that the primary promoter region for <italic>ramR</italic> transcription is located at the -83T start site (<xref ref-type="supplementary-material" rid="ppat.1004627.s001">S1</xref> and <xref ref-type="supplementary-material" rid="ppat.1004627.s002">S2</xref> Figs.). This site is also repressed 5-fold more than the vector only control by <italic>ramR</italic> in trans indicating that like other TetR-type regulators, RamR expression is autoregulated (<xref ref-type="supplementary-material" rid="ppat.1004627.s002">S2 Fig.</xref>).</p><p>Previous work in <italic>Salmonella</italic> has shown that the regulatory RNA, StyR3, can control expression at the <italic>ram</italic> locus [<xref rid="ppat.1004627.ref024" ref-type="bibr">24</xref>]. Given the expansive role of <italic>ramA</italic> in gene regulation, we sought to determine whether the <italic>K. pneumoniae</italic> ortholog of StyR3, denoted as sRamA5, would function as co-regulator of <italic>ramA</italic> expression in <italic>K. pneumoniae</italic> to promote basal <italic>ramA</italic> levels. The lack of similarity within the intergenic regions located between the <italic>ramR</italic> and <italic>romA-ramA</italic> genes or <italic>ramR</italic> and <italic>ramA</italic> genes in <italic>K. pneumoniae</italic> and <italic>Salmonella</italic> spp. respectively, excluded the possibility of using sequence analyses to identify the StyR3 ortholog. Direct northern blot analyses of RNA derived from <italic>K. pneumoniae</italic> strain Ecl8 and its derivatives did not produce a detectable signal for the putative regulatory RNA, sRamA5. Thus in order to demonstrate the presence of sRamA5, we cloned the entire intergenic region flanked by the <italic>ramR</italic> and <italic>romA</italic> genes and the partial <italic>romA</italic> open reading frame into the TA cloning vector pGEMTeasy to generate pGEMsRamA5. Northern blot analyses derived from the expression of sRamA5 encoded on pGEMsRamA5, using gene specific probes for sRamA5 and <italic>romA</italic> ORF, demonstrate the presence of sRamA5 (~ 60nt) (shown in <xref ref-type="fig" rid="ppat.1004627.g002">Fig. 2A</xref>). Notably, the sRamA5 specific probe also detected a further two RNA molecules (<xref ref-type="fig" rid="ppat.1004627.g002">Fig. 2A</xref>, arrowed bands 1 and 2). These fragments, detected by both the sRamA5 and <italic>romA</italic> specific probe, possibly represent primary transcripts initiated from the common start site as determined by 5&#x02019; RACE analyses for sRamA5 and <italic>romA</italic> (<xref ref-type="supplementary-material" rid="ppat.1004627.s001">S1 Fig.</xref>). As expected the <italic>romA</italic> specific probe did not detect the 60nt sRamA5 molecule (<xref ref-type="fig" rid="ppat.1004627.g002">Fig. 2A</xref>). Thus we surmise that sRamA5 and <italic>romA</italic> are co-transcribed into a primary RNA molecule, which undergoes further processing prior to excision proximal to the start of the <italic>romA</italic> gene, thereby producing sRamA5.</p><fig id="ppat.1004627.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1004627.g002</object-id><label>Figure 2</label><caption><title>A: Northern blot analysis of sRamA5.</title><p>15 &#x003bc;g of total RNA extracted from Ecl8/pGEMTpI+<italic>romA</italic> were loaded into wells. The blots were either incubated with the <sup>32</sup>P-end labelled sRamA5 specific DNA probe or <italic>romA</italic> specific DNA probe. The bands pointed as 1 and 2 are primary transcripts for both the RNA codes for sRamA5 and <italic>romA</italic>. The band referred to as sRamA5 is specifically detected by the sRamA5 DNA probe, sized at around 60 nucleotides; the band referred to as <italic>romA</italic> was specifically detected by the <italic>romA</italic> DNA probe. <bold>B:</bold> EMSA of RamR-sRamA5 or RamR-PI interaction in the presence of sRamA5. (i). RamR-sRamA5 interaction. The concentrations of sRamA5 and RamR were 40 nM and 1 &#x003bc;M respectively. (ii). RamR-pI interaction in the absence/presence of sRamA5. Radioactive labeled pI was 2 nM from lane 1 to 4. RamR&#x02019;s concentrations from lane 1 to 4 were: 0, 2, 0, 2 &#x003bc;M. Cold sRamA5&#x02019;s concentrations from lane 1 to 4 were: 0, 0, 1, 1 &#x003bc;M. F<sub>R</sub> = free RNA, C<sub>R</sub> = RNA-protein complex, F<sub>D</sub> = free DNA, C = RNA-DNA-protein complex. <bold>C:</bold> qPCR for the level of <italic>romA</italic> and sRamA5&#x02019;s transcriptions in Ecl8&#x00394;<italic>ramR</italic>. qPCR using LNA probe for determining the levels of sRamA5 transcription in Ecl8 and Ecl8&#x00394;<italic>ramR</italic>. Despite sharing the same TSS, the transcript levels of sRamA5 are not linked to <italic>romA</italic> levels, thereby reducing the likelihood of sRamA5 being a 5&#x02019; untranslated region of <italic>romA</italic>. The log<sub>2</sub> fold changes in Ecl8&#x00394;<italic>ramR</italic> displayed in the bar chart are relative to their transcript levels in Ecl8. One-way ANOVA analyses (P&#x0003c;0.001) were performed to demonstrate statistical significance. <bold>D:</bold> qPCR assay for the level of <italic>ramR</italic>, <italic>romA</italic> and sRamA5 in Ecl8&#x00394;<italic>ramR</italic> pACYC<italic>ramR</italic> and Ecl8&#x00394;<italic>ramR</italic> pACYC177. The log<sub>2</sub> fold changes in the two strains displayed in the bar chart are relative to their transcript levels in Ecl8&#x00394;<italic>ramR</italic>. sRamA5 levels are elevated in the presence of <italic>ramR</italic>, implying that RamR could stabilise the sRamA5 transcript. One-way ANOVA analyses (P&#x0003c;0.001) were performed to demonstrate statistical significance.</p></caption><graphic xlink:href="ppat.1004627.g002"/></fig><p>As a classical TetR-family protein, RamR-mediated repression of the <italic>romA-ramA</italic> locus is likely to be perturbed through ligand-mediated interactions; therefore we hypothesized that to function as a co-regulator of <italic>romA-ramA</italic> expression RamR would interact with sRamA5. RNA-EMSA (<xref ref-type="supplementary-material" rid="ppat.1004627.s007">S1 Text</xref>) analyses demonstrate that RamR and sRamA5 form a complex, suggesting direct interaction of the RNA (sRamA5) with RamR (<xref ref-type="fig" rid="ppat.1004627.g002">Fig. 2B</xref>). In order to ascertain whether the interaction of sRamA5 and RamR is attributable to the presence of the highly conserved IR sequence in the <italic>ramR-romA</italic> inetrgenic region (ATGAGTGcgtactCACTCAT) and thus, act as a competitor for RamR-pI binding, we performed EMSA analyses using the pI promoter, sRamA5 and RamR. Our results show a reduction in affinity of RamR to sRamA5 in the presence of excess pI promoter (<xref ref-type="fig" rid="ppat.1004627.g002">Fig. 2B</xref>). In contrast, competition experiments with excess sRamA5 show no perturbation of the pI+RamR interaction, suggesting that RamR has a higher affinity for the pI promoter compared to sRamA5 (<xref ref-type="fig" rid="ppat.1004627.g002">Fig. 2B</xref>).</p><p>Simultaneous qPCR measurements utilizing an LNA probe to assess sRamA5 levels demonstrate firstly, that the transcription levels of sRamA5 and <italic>romA</italic> are not linked as sRamA5 levels are decreased in contrast to elevated <italic>romA</italic> levels (<xref ref-type="fig" rid="ppat.1004627.g002">Fig. 2C</xref>). This suggests that despite being transcribed from the same TSS, sRamA5 and <italic>romA</italic> are likely subject to different rates of degradation. Secondly, the stability of sRamA5 may be dependent on the presence of a functional RamR. In order to investigate the requirement for a functional RamR in sRamA5 stability, we determined both the <italic>romA</italic> and sRamA5 levels in Ecl8&#x00394;<italic>ramR</italic> before and after complementation with <italic>ramR</italic> expressed in <italic>trans</italic>. As expected, our results show that the level of <italic>romA</italic> transcription was reduced (&#x0223c; 30-fold) in Ecl8&#x00394;<italic>ramR</italic>/pAC<italic>ramR</italic> compared to the plasmid only control (Ecl8&#x00394;<italic>ramR</italic>/pACYC177) (<xref ref-type="fig" rid="ppat.1004627.g002">Fig. 2D</xref>). In contrast, the levels of sRamA5 were found upregulated by &#x0223c; 2.8 fold in Ecl8&#x00394;<italic>ramR</italic>/pAC<italic>ramR</italic> relative to the plasmid only control (Ecl8&#x00394;<italic>ramR</italic>/pACYC177). Thus the increase in sRamA5 levels in the presence of a functional <italic>ramR</italic> supports our hypothesis that sRamA5 is stabilized by RamR. Our data also shows that sRamA5 does compete with pI for RamR binding, although this effect may be abrogated by the higher relative affinity of RamR to the pI promoter (<xref ref-type="fig" rid="ppat.1004627.g002">Fig. 2B(ii)</xref>). Therefore, we surmise that the physiological relevance of RamR-sRamA5 interaction supports the basal level of <italic>ramA</italic> transcription detected in the wild type <italic>K. pneumoniae</italic> Ecl8.</p></sec><sec id="sec002b"><title>Describing the Transcriptional Landscape of <italic>K. pneumoniae</italic> Ecl8 and Its Isogenic Derivatives Ecl8&#x00394;<italic>ramA</italic>, Ecl8&#x00394;<italic>ramR</italic></title><p>To determine the effect of altered RamA levels on the whole transcriptome of <italic>K. pneumoniae</italic> strain Ecl8, we quantitatively compared the transcriptomes of the three strains (Ecl8, Ecl8&#x00394;<italic>ramA</italic>, Ecl8&#x00394;<italic>ramR</italic>) using the Kolmogorov-Smirnov (K-S) 2-sample test (<xref ref-type="supplementary-material" rid="ppat.1004627.s003">S3 Fig.</xref>) as described in the supplementary data [<xref rid="ppat.1004627.ref025" ref-type="bibr">25</xref>]. As expected, the distribution curve of Ecl8 and Ecl8&#x00394;<italic>ramA</italic> were more similar to each other compared to that observed for Ecl8&#x00394;<italic>ramR</italic>, suggesting that under normal growth conditions the deletion of <italic>ramA</italic> is less likely to perturb the transcriptional landscape as opposed to when it is overexpressed. This supports the notion that <italic>ramA</italic> functions as a pleiotropic regulator of gene expression in <italic>K. pneumoniae</italic>.</p><p>In all three strains, the 16S and 23S rRNA genes showed the highest number of mapped reads consistent with the lack of depletion for ribosomal RNA. However, pairwise comparisons of the normalized basemean values associated with these ribosomal regions were not differentially expressed between Ecl8 and Ecl8&#x00394;<italic>ramR</italic> or Ecl8 and Ecl8&#x00394;<italic>ramA</italic>. The lack of differential ribosomal gene expression is contrary to previous observations in <italic>Salmonella enterica</italic> serovar Typhimurium [<xref rid="ppat.1004627.ref004" ref-type="bibr">4</xref>]. Other non-ribosomal genes (e.g. <italic>fusA</italic>_1 (encoding translation elongation factor G), <italic>atpA</italic> (producing ATP synthase F1, &#x003b1; subunit) and <italic>aceE</italic> (encoding a pyruvate dehydrogenase)) were also found to have significantly high basemean values relative to most other genes within the genome. The increased expression of these genes is perhaps not surprising as <italic>atpA</italic> is associated with aerobic growth and <italic>aceE</italic> catalyses the production of precursors to the TCA cycle.</p><p>Potential regions of antisense transcription were also detected. However, in most cases, these regions appeared as antisense because of <italic>in silico</italic> errors in annotation or due to transcriptional noise from flanking genes within the chromosome. We did, however, identify antisense transcription, such as with BN373_16241 (producing an oxidoreductase) and BN373_02611, which were differentially expressed due to either elevated RamA levels or loss of the <italic>ramA</italic> gene (<xref ref-type="supplementary-material" rid="ppat.1004627.s004">S4 Fig.</xref>). Coverage plots analyses indicate that the transcription associated with BN373_02611 may be associated with 3&#x02019;UTR runoff transcription from the divergently transcribed <italic>treBC</italic> operon, in contrast to BN373_16241, which is upregulated when <italic>ramA</italic> was overexpressed and may be a &#x0201c;true&#x0201d; antisense RNA (<xref ref-type="supplementary-material" rid="ppat.1004627.s004">S4 Fig.</xref>).</p><p>Genome analyses of <italic>K. pneumoniae</italic> strain Ecl8 [<xref rid="ppat.1004627.ref023" ref-type="bibr">23</xref>] identified 11 unique predicted prophage genes encoding phage structural components (BN373_03311, BN373_09871, BN373_10091, BN373_14801, BN373_14811, BN373_14821, BN373_14841, BN373_14921, BN373_21511, BN373_37361, BN373_37371) which were not found to be differentially transcribed in the pairwise comparisons tested (Ecl8 vs Ecl8&#x02206;<italic>ramA</italic>, Ecl8 vs Ecl8&#x02206;<italic>ramR</italic> (<xref ref-type="supplementary-material" rid="ppat.1004627.s008">S1 Table</xref>). However, pairwise comparisons of Ecl8&#x00394;<italic>ramA</italic> and Ecl8&#x00394;<italic>ramR</italic> detected the differential expression of Ecl8-genome specific genes, BN373_33401, BN373_33411, which were repressed (&#x0223c;2&#x02013;3 fold) in the <italic>ramA</italic> overexpressing strain Ecl8&#x00394;<italic>ramR</italic> (<xref ref-type="supplementary-material" rid="ppat.1004627.s009">S2 Table</xref>). Of note, no differential gene expression was noted in the 233 plasmid-coding genes in the <italic>ramA</italic> null mutant or in the <italic>ramA</italic> overexpressor (Ecl8&#x00394;<italic>ramR</italic>) with respect to the wild type (Ecl8).</p></sec><sec id="sec002c"><title>Defining the RamA Regulon</title><p>Transcriptome analyses underscores that perturbations in RamA levels can result in the differential expression of open reading frames, antisense transcripts and Ecl8-specific genes. As the majority of reads were mapped to open reading frames, the main focus of our analyses relates to the differential regulation of genes within <italic>K. pneumoniae</italic>. The RamA regulon in <italic>K. pneumoniae</italic> was identified by pairwise comparisons of Ecl8&#x02206;<italic>ramR</italic> versus Ecl8 (C) or Ecl8&#x02206;<italic>ramA</italic> (B). The pairwise comparisons of Ecl8 versus Ecl8&#x02206;<italic>ramA</italic> (A)(<xref ref-type="fig" rid="ppat.1004627.g003">Fig. 3</xref>) indicate the cohort of genes (<underline>13</underline>) responsive to basal levels of RamA expression; the contrast between Ecl8 versus Ecl8&#x02206;<italic>ramR</italic> (<underline>35</underline>) specifies genes that are either affected by RamR or RamA, whereas the comparison between Ecl8&#x02206;<italic>ramR</italic> versus Ecl8&#x02206;<italic>ramA</italic> (<underline>77</underline>) identifies genes that largely react to altered RamA levels. As fewer genes are affected due to perturbations in <italic>ramR</italic> expression as opposed to RamA levels, we surmise that the majority of genes differentially expressed in our pairwise comparison (B) are associated with RamA-mediated regulation. Based on this assessment, the probable RamA regulon, <xref ref-type="fig" rid="ppat.1004627.g003">Fig. 3</xref>, constitutes a total of 103 genes (as in genes in categories A, B, AB, BC, CA, ABC) (<xref ref-type="supplementary-material" rid="ppat.1004627.s009">S2 Table</xref>). Of these, 68 genes were found to be activated and 35 were repressed (<xref ref-type="supplementary-material" rid="ppat.1004627.s009">S2 Table</xref>) when levels of RamA is relatively higher.</p><fig id="ppat.1004627.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1004627.g003</object-id><label>Figure 3</label><caption><title>Venn diagram representing the RNA sequencing results.</title><p>Ecl8&#x00394;<italic>ramA</italic> or Ecl8&#x00394;<italic>ramR</italic> were used as calibrators in the pairwise comparisons. The arrows &#x02b07; indicates a lower than 0.5 fold decrease in transcription compared to calibrator; &#x02b06; indicates a higher than 2 fold transcription compared to calibrator. The numbers beneath A, B and C indicate the number of transcripts showing higher or lower transcription (based on statistical cut-off) compared to calibrator. The genes under the different categories A, B and C represent pairwise comparisons between Ecl8/Ecl8&#x00394;<italic>ramA</italic>, Ecl8&#x00394;<italic>ramR</italic>/Ecl8&#x00394;<italic>ramA</italic> and Ecl8/Ecl8&#x00394;<italic>ramR</italic> comparison respectively; the genes in Area AB were found to be differentially transcribed in both the Ecl8/Ecl8&#x00394;<italic>ramA</italic> and the Ecl8&#x00394;<italic>ramR</italic>/Ecl8&#x00394;<italic>ramA</italic> comparisons; the genes in Area AC were found to be differentially transcribed in both the Ecl8/Ecl8&#x00394;<italic>ramA</italic> and the Ecl8/Ecl8&#x00394;<italic>ramR</italic> comparisons; the genes found in the area BC were found to be differentially transcribed in both the Ecl8/Ecl8&#x00394;<italic>ramR</italic> and Ecl8&#x00394;<italic>ramR</italic>/Ecl8&#x00394;<italic>ramA</italic> comparisons. The <italic>romA</italic> gene in Area ABC was found to be differentially transcribed in all the three comparisons.</p></caption><graphic xlink:href="ppat.1004627.g003"/></fig><p>Genes associated with RamA-mediated regulation were initially mapped to the COG (clusters of orthologous groups) database to explore their biological function. COG functional classifications of the significantly differentially expressed genes reveal that RamA controls a myriad of cellular and metabolic processes (COG data presented in <xref ref-type="supplementary-material" rid="ppat.1004627.s009">S2 Table</xref>). Generally, altered levels of RamA significantly modulate the expression of genes belonging to the COG functional group C (energy production and conversion). Specifically, when <italic>ramA</italic> is deleted, genes within the COG (G) (carbohydrate metabolism and transport) were also found to be differentially regulated. Pairwise comparison between Ecl8&#x00394;<italic>ramR</italic> versus Ecl8 indicates that COG families associated with transcription (K) and inorganic ion transport and metabolism (P) were also affected. Additionally, when <italic>ramA</italic> levels are elevated genes associated with cell wall membrane and envelope biogenesis (M), transcription (K) and Function UnknowN (FUN) categories were most differentially affected. Thus the resulting COG analyses also supports the observation where altered levels of RamA triggers a shift in gene functionality consistent with significant modulations in transcription patterns as predicted by the K-S test (<xref ref-type="supplementary-material" rid="ppat.1004627.s003">S3 Fig.</xref>).</p><p>A closer analyses of the genes associated with pairwise comparisons of Ecl8&#x00394;<italic>ramA</italic> versus Ecl8&#x00394;<italic>ramR</italic> reveals that firstly, the highest number of genes (<underline>77</underline>) are differentially expressed and secondly genes (<italic>yhbW</italic>, <italic>nfnB</italic>, <italic>acrAB</italic>, <italic>ybhT</italic>, <italic>yrbB-F</italic>) associated with the previously characterized networks for MarA [<xref rid="ppat.1004627.ref001" ref-type="bibr">1</xref>], SoxS [<xref rid="ppat.1004627.ref026" ref-type="bibr">26</xref>] or Rob [<xref rid="ppat.1004627.ref003" ref-type="bibr">3</xref>] in <italic>E. coli</italic> or RamA in <italic>Salmonella enterica</italic> serovar Typhimurium [<xref rid="ppat.1004627.ref004" ref-type="bibr">4</xref>, <xref rid="ppat.1004627.ref011" ref-type="bibr">11</xref>] are also affected. This is consistent with previous observations that demonstrate that these proteins exhibit considerable gene overlap within the regulons [<xref rid="ppat.1004627.ref001" ref-type="bibr">1</xref>, <xref rid="ppat.1004627.ref004" ref-type="bibr">4</xref>, <xref rid="ppat.1004627.ref011" ref-type="bibr">11</xref>]. Importantly, RamA overexpression results in the modulation of efflux pump genes such as <italic>acrAB</italic>, <italic>oqxAB</italic> and <italic>yrbB-F</italic>, which is consistent with phenotypes linked to multidrug resistance [<xref rid="ppat.1004627.ref027" ref-type="bibr">27</xref>] and susceptibility to toxic small molecules, which is associated with alterations in the lipid symmetry of the cell wall [<xref rid="ppat.1004627.ref028" ref-type="bibr">28</xref>]. However, the pairwise comparisons for Ecl8 and Ecl8&#x00394;<italic>ramA</italic> also suggest that basal levels of RamA are sufficient to trigger the upregulation of genes such as the trehalose transporter operon <italic>treBC</italic> and the ribose ABC transporter, <italic>rbsACB</italic>. Uniquely, genes associated with biofilm formation (<italic>hha-ybaJ</italic> encodes a toxin-antitoxin system) and lipid A biosynthesis BN373_10601 (encodes lipid A biosynthesis lauroyl acyltransferase, <italic>lpxL_2</italic>) and the related dioxygenase protein encoding gene <italic>lpxO</italic> (BN373_36331) were also found to be upregulated by RamA.</p><p>A total of 51 genes were found to be downregulated. As expected, <italic>ompF</italic> was significantly repressed in the <italic>ramA</italic> overexpresser (Ecl8&#x02206;<italic>ramR</italic>) (<xref ref-type="fig" rid="ppat.1004627.g003">Fig. 3</xref>) in addition to genes encoding the nitrate reductases (<italic>narGHJI</italic> operon and <italic>nirD</italic>), BN373_05601 encoding the LysR-type transcriptional regulator, elongation factor EF2 and the riboflavin synthase encoding gene <italic>ribH</italic> were also found to be significantly downregulated in the <italic>ramA</italic> overexpresser (Ecl8&#x02206;<italic>ramR</italic>).</p><p>Only a subset of those differentially regulated genes was chosen for validation using qPCR. As expected, both the <italic>romA</italic> and <italic>ramA</italic> genes were found to show 5.25-log<sub>2</sub> fold and 14.5- log<sub>2</sub> fold increase in Ecl8&#x02206;<italic>ramR</italic> respectively compared to Ecl8&#x02206;<italic>ramA</italic> (<xref ref-type="supplementary-material" rid="ppat.1004627.s005">S5A Fig.</xref>). When the activated genes (with the exception of <italic>romA</italic>, <italic>ramA</italic>) were assessed, increased expression of the following genes was noted (<xref ref-type="fig" rid="ppat.1004627.g004">Fig. 4A</xref>): <italic>tolC</italic> (4.8- log<sub>2</sub> fold), <italic>acrA</italic> (4.6- log<sub>2</sub> fold), <italic>yhbW</italic> (1.8- log<sub>2</sub> fold), <italic>yrbC</italic> (2.8- log<sub>2</sub> fold), <italic>nfnB</italic> (3.3- log<sub>2</sub> fold), <italic>ybjP</italic> (3.95- log<sub>2</sub> fold), <italic>adhP</italic> (3.2- log<sub>2</sub> fold), BN373_36191 (encodes putative membrane protein, 2.95- log<sub>2</sub> fold), BN373_39031 (encodes oxidoreductase, aldo/keto reductase family, 1.5- log<sub>2</sub> fold), <italic>lpxO</italic> (2.8- log<sub>2</sub> fold) and <italic>lpxL-2</italic> (3.6- log<sub>2</sub> fold). As expected, the levels of the <italic>ompF</italic> (4.2- log<sub>2</sub> fold down) and BN373_03291 (encodes conserved hypothetical protein, 1.1- log<sub>2</sub> fold down) were also downregulated (<xref ref-type="fig" rid="ppat.1004627.g004">Fig. 4A</xref>).</p><fig id="ppat.1004627.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1004627.g004</object-id><label>Figure 4</label><caption><title>A: Quantitative real-time RT-PCR validation of differentially expressed genes in Ecl8&#x02206;<italic>ramR</italic>.</title><p>All qPCR experiments were performed as outlined in <xref ref-type="sec" rid="sec004">materials and methods</xref>. Expression levels were normalized to 16S levels, and fold change values were generated by calibrating against Ecl8&#x02206;<italic>ramA</italic>. Genes designated BN373_36191, BN373_39031, BN373_03291 encode a putative membrane protein, oxidoreductase family and conserved hypothetical protein respectively. All data is a mean of 3 experiments. <bold>B:</bold> Electrophoretic Mobility Shift Assay (EMSA) using purified RamA protein. Following PCR amplification, each promoter region was end-labelled with <sup>32</sup>P-&#x003b3; ATP. Purified RamA (200 nM) and the different labelled DNA probes (2 nM) were incubated on ice. All reactions were performed on ice prior to electrophoresis on 7.5% native gel. Lane 1 of each panel indicates the labelled DNA probe only, Lane 2 is the BSA control and Lane 3 contains RamA+DNA. <bold>C:</bold> Transcription <italic>in vitro</italic> assay of different promoters using the purified RamA protein. The test DNA (2 nM- <italic>yrbF</italic>, <italic>ybhT</italic>, <italic>yhbW</italic>, <italic>acrA</italic>, <italic>nfnB</italic>, <italic>lpxO</italic> and <italic>lpxC</italic>) with the control template (<italic>gnd</italic>) were incubated for transcription <italic>in vitro</italic> [<sup>32</sup>P]&#x003b1;-UTP with (+) or without (-) 200 nM purified RamA. Samples were fractionated by polyacrylamide/urea gel electrophoresis prior to drying and exposure to the phosphorimager. Relative fold increase was determined using densitometric analysis as described previously [<xref rid="ppat.1004627.ref055" ref-type="bibr">55</xref>], by first normalizing all test transcription levels to the control promoter (<italic>gnd</italic>) prior to comparison to the no protein control. Statistics was done using One way ANOVA (P value &#x0003c; 0.05) where transcription levels were found to be statistically significant in the presence of purified RamA compared to the no protein control.</p></caption><graphic xlink:href="ppat.1004627.g004"/></fig></sec><sec id="sec002d"><title>Direct Regulation by RamA</title><p>In order to determine if some of these differentially expressed genes were under the direct or indirect control of RamA, we performed both EMSA and <italic>in vitro</italic> transcription (IVT) using purified recombinant RamA protein. The EMSA results show that RamA directly binds the <italic>yrbF</italic>, <italic>ybhT</italic>, <italic>yhbW</italic>, <italic>acrA</italic>, <italic>nfnB</italic>, <italic>adhP</italic>, <italic>lpxO</italic> and <italic>lpxL-2</italic> promoters (<xref ref-type="fig" rid="ppat.1004627.g004">Fig. 4B</xref>). Of note, our controls, showed no shift in the presence of the test promoters (<xref ref-type="fig" rid="ppat.1004627.g004">Fig. 4B</xref>).</p><p>We then determined whether RamA would directly regulate the different promoters identified. By performing IVT experiments, we initially tested the effects of the RamA protein against the <italic>acrAB</italic> promoter to ascertain if RamA would function correctly as a transcriptional activator. As expected, the purified recombinant RamA activated the <italic>acrAB</italic> promoter directly (<xref ref-type="fig" rid="ppat.1004627.g004">Fig. 4C</xref>) thereby confirming the biological activity of the purified RamA protein. Subsequently, we assessed the test promoters identified by the EMSA in our IVT assays. The results show that RamA upregulates <italic>yrbF</italic> (4-fold), <italic>ybhT</italic> (3-fold), <italic>yhbW</italic> (6.9-fold), <italic>acrA</italic> (4-fold), <italic>nfnB</italic> (10-fold), <italic>lpxO</italic> (8-fold) and <italic>lpxL-2</italic> (&#x0223c;3-fold) (<xref ref-type="fig" rid="ppat.1004627.g004">Fig. 4C</xref>). Thus purified recombinant RamA alone can directly activate the expression of these promoters <italic>in vitro</italic>.</p></sec><sec id="sec002e"><title>Functional Relevance of RamA-Mediated Overexpression</title><p><bold>RamA regulates genes involved in lipid A biosynthesis</bold>. Having established that purified RamA directly binds and activates the expression of <italic>lpxL-2</italic> and <italic>lpxO</italic> gene promoters (<xref ref-type="fig" rid="ppat.1004627.g004">Fig. 4B and 4C</xref>), we sought to determine whether RamA could regulate other genes associated with the lipid A biosynthetic pathway. The lipid A biosynthetic pathway is governed by nine enzymes encoded by <italic>lpxA</italic>, <italic>lpxC</italic>, <italic>lpxD</italic>, <italic>lpxB</italic>, <italic>lpxK</italic>, <italic>lpxl</italic>, <italic>lpxM and lpxO</italic> genes [<xref rid="ppat.1004627.ref029" ref-type="bibr">29</xref>]. Gene expression analyses using qPCR showed that with the exception of <italic>lpxC</italic>, none of the other <italic>lpx</italic> genes showed significant differential expression in Ecl8&#x00394;<italic>ramR</italic> in comparison to Ecl8 or Ecl8&#x00394;<italic>ramA</italic> (<xref ref-type="fig" rid="ppat.1004627.g005">Fig. 5A</xref>). We then chose to assess whether RamA would directly interact with the <italic>lpxC</italic> and <italic>lpxK</italic> promoter regions. Subsequent EMSA analyses demonstrate that RamA directly interacts with the <italic>lpxC</italic> but not the <italic>lpxK</italic> promoter (<xref ref-type="fig" rid="ppat.1004627.g005">Fig. 5Bi</xref>) and increased <italic>lpxC</italic> transcription (9-fold) in the presence of purified RamA and RNA polymerase (<xref ref-type="fig" rid="ppat.1004627.g005">Fig. 5Bii</xref>). Previous work has shown that the control of lipid A biosynthetic genes is mediated by the PhoPQ or PmrAB systems [<xref rid="ppat.1004627.ref030" ref-type="bibr">30</xref>]. Further interrogation of the transcriptome data and subsequent qPCR analyses shows that the levels for <italic>phoP</italic> and <italic>pmrA</italic> levels remained unchanged in <italic>K. pnuemoniae</italic> Ecl8, Ecl8&#x00394;<italic>ramA</italic> and Ecl8&#x00394;<italic>ramR</italic>. Thus the differential modulation of the <italic>lpxO</italic>, <italic>lpxC</italic> and <italic>lpxL-2</italic> genes is directly linked to increased RamA levels.</p><fig id="ppat.1004627.g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1004627.g005</object-id><label>Figure 5</label><caption><title>A. Gene Expression analyses of <italic>lpx</italic> genes.</title><p>All qPCR experiments were performed as outlined in <xref ref-type="sec" rid="sec004">materials and methods</xref>. Expression levels were normalized to 16S levels, and fold change values were generated by calibrating against Ecl8&#x02206;<italic>ramA</italic>. Two-way ANOVA analyses (P&#x0003c;0.05) were performed to demonstrate statistical significance. <bold>B.</bold> Regulation of <italic>lpx</italic> genes. (i) EMSA using <italic>lpxC</italic> and <italic>lpxK</italic> promoter regions. Purified RamA (200nM) and the different labelled DNA probes (2 nM) were incubated on ice. All reactions were performed on ice prior to electrophoresis on 7.5% native gel. (ii) Transcription <italic>in vitro of lpxC</italic> promoter region. Relative fold increase was determined using densitometric analysis as described previously [<xref rid="ppat.1004627.ref055" ref-type="bibr">55</xref>]. Fold increases in the presence of RamA were determined by first normalising to the control promoter (<italic>gnd</italic>) prior to comparison to the no protein control. <bold>C:</bold> Lipid A analysis from <italic>K. pneumoniae</italic> Ecl8 (WT), Ecl8&#x00394;<italic>ramA</italic>, Ecl8&#x00394;<italic>ramR</italic> and Ecl8&#x00394;<italic>ramRA</italic>. Lipid A analysis was undertaken as described before [<xref rid="ppat.1004627.ref031" ref-type="bibr">31</xref>]. Negative ion MALDI-TOF mass spectrometry of lipid A isolated from <italic>K. pneumoniae</italic> Ecl8 and its derivatives. Peaks in bold correspond to LpxO dependent 2&#x02019; secondary chain modifications.</p></caption><graphic xlink:href="ppat.1004627.g005"/></fig><p>To ascertain whether RamA-mediated transcriptional activation of <italic>lpxC</italic>, <italic>lpxL</italic>-2 and <italic>lpxO</italic> would actually result in modifications within the lipid A moiety, we performed MALDI TOF mass spectrometry (<xref ref-type="supplementary-material" rid="ppat.1004627.s007">S1 Text</xref> for details). The mass spectrometry analyses confirm alterations in lipid A structure of the <italic>ramA</italic> overexpresser, Ecl8&#x00394;<italic>ramR</italic> compared to the wild type (Ecl8), the null mutant (Ecl8&#x00394;<italic>ramA</italic>) or the double mutant (Ecl8&#x00394;<italic>ramRA</italic>) (<xref ref-type="fig" rid="ppat.1004627.g005">Fig. 5C</xref>) where peaks (m/z 1840, 1866 and 2079) were found to be elevated. Previous studies in <italic>K. pneumoniae</italic> [<xref rid="ppat.1004627.ref031" ref-type="bibr">31</xref>, <xref rid="ppat.1004627.ref032" ref-type="bibr">32</xref>] indicate that those peaks correspond to LpxO hydroxylated lipid A species containing a hydroxymyristate group at position 2&#x02019; as secondary acyl substitution. Therefore, we surmise that RamA mediated activation of the different lipid A biosynthetic genes leads to alterations within the lipid A moiety in <italic>K. pneumoniae</italic>.</p></sec><sec id="sec002f"><title>Antibiotic Susceptibility</title><p><bold>Phenotype microarray analyses</bold>. In order to assign phenotypes linked to the differentially regulated genes, Biolog phenotype assays were undertaken for <italic>K. pneumoniae</italic> Ecl8 and its isogenic derivatives Ecl8&#x00394;<italic>ramA</italic> and Ecl8&#x00394;<italic>ramR</italic>. A comparison of Biolog phenotypic profiles of both <italic>Salmonella</italic> [<xref rid="ppat.1004627.ref011" ref-type="bibr">11</xref>] and <italic>K. pneumoniae</italic> generally indicates a significant overlap in the susceptibilities to antimicrobial and toxic compounds (<xref ref-type="supplementary-material" rid="ppat.1004627.s010">S3 Table</xref>). As expected, the overexpression of <italic>ramA</italic> resulted in increased tolerance of Ecl8&#x00394;<italic>ramR</italic> in the presence of antimicrobials such as tetracyclines (doxycycline, chlortetracycline, minocycline), macrolides (erythromycin, spiramycin, troleandomycin), beta-lactams (1st, 2nd, 3rd generation cephalosporins, penams) and (fluoro)quinolones (ciprofloxacin, ofloxacin, nalidixic acid, novobiocin), fungicides (such as chloroxylenol, dodine, domiphen bromide) and toxic anions (potassium tellurite, sodium metasilicate) (<xref ref-type="supplementary-material" rid="ppat.1004627.s010">S3 Table</xref>, <xref ref-type="supplementary-material" rid="ppat.1004627.s006">S6 Fig.</xref>). Notably, comparisons of the Biolog data also indicate that <italic>ramA</italic> overexpression results in altered polymyxin B susceptibility levels in both <italic>K. pneumoniae</italic> and <italic>Salmonella</italic>.</p></sec><sec id="sec002g"><title>Susceptibilities to the Polymyxins and the Cationic Antimicrobial Peptides (cAMPs)</title><p>Lipid A synthesis in Gram-negative bacteria is controlled at both the transcriptional and translational levels, where alterations in the lipid A profile can result in perturbations in host-microbe interactions as well as reductions in susceptibility to both the polymyxins and the cationic antimicrobial peptides (cAMPs) [<xref rid="ppat.1004627.ref033" ref-type="bibr">33</xref>]. Accordingly, we tested the strain Ecl8 and its isogenic derivatives Ecl8&#x00394;<italic>ramA</italic>, Ecl8&#x00394;<italic>ramR</italic> against colistin, polymyxin B and the cAMP LL-37. The relative survival assays for colistin, polymyxin B and LL-37 demonstrated that the <italic>ramA</italic> overexpressing strain, Ecl8&#x00394;<italic>ramR</italic> strain was significantly (P &#x0003c; 0.05) less susceptible to polymyxin B, colistin and LL-37 (<xref ref-type="fig" rid="ppat.1004627.g006">Fig. 6 A, B, C</xref>) compared to the wild type Ecl8 and the null mutant Ecl8&#x00394;<italic>ramA</italic>. The reduction in polymyxin susceptibility, as noted in the survival assays, is also supported by the Biolog data (<xref ref-type="supplementary-material" rid="ppat.1004627.s010">S3 Table</xref>). Taken together these results suggest that RamA-dependent regulation provides an alternative pathway for reduced susceptibility to polymyxins and cAMPs.</p><fig id="ppat.1004627.g006" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1004627.g006</object-id><label>Figure 6</label><caption><title>Survival assay of <italic>K. pneumoniae</italic> (Ecl8, Ecl8&#x02206;<italic>ramA</italic>, Ecl8&#x02206;<italic>ramR</italic>, Ecl8&#x02206;<italic>ramRA</italic>) to polymyxin B, colistin and the antimicrobial peptide LL-37.</title><p>The relative survival of bacteria (expressed as a percentage of the number of colonies obtained from the unexposed control of the same strain) in the presence of different concentrations of polymyxin B (A), colistin (B) and LL-37 (C) are shown. Asterisks indicate that results obtained for the <italic>ramA</italic> expresser, Ecl8&#x00394;<italic>ramR</italic> is significantly different (P &#x0003c; 0.05 by Two-way ANOVA) compared to Ecl8, Ecl8&#x00394;<italic>ramA</italic> and Ecl8&#x02206;<italic>ramRA</italic>.</p></caption><graphic xlink:href="ppat.1004627.g006"/></fig></sec><sec id="sec002h"><title>Effect of RamA Overexpression on Host-Microbe Interactions</title><p><bold>Macrophage-<italic>Klebsiella</italic> interaction</bold>. To ascertain whether RamA-mediated alterations can have an impact on microbe-macrophage interactions, we examined if Ecl8 and its isogenic derivatives, Ecl8&#x00394;<italic>ramR</italic>, Ecl8&#x00394;<italic>ramA</italic> and Ecl8&#x00394;<italic>ramRA</italic> would exhibit differential interactions in adherence and intracellularization into murine RAW macrophages. In the adhesion and intracellularization assays, the <italic>ramA</italic> overexpresser, Ecl8&#x00394;<italic>ramR</italic>, was significantly attenuated in its ability (approximately 50% decrease) to attach to and internalise into the RAW murine macrophage cells compared to wild type <italic>K. pneumoniae</italic> Ecl8, the mutants Ecl8&#x00394;<italic>ramA</italic> and Ecl8&#x00394;<italic>ramRA</italic> (<xref ref-type="fig" rid="ppat.1004627.g007">Figs. 7A, B and C</xref>). Two possible explanations exist for the reduction in adherence and intracellularization of Ecl8&#x00394;<italic>ramR</italic>; the first, where altered RamA levels confers resistance to phagocytosis and the second, is due to accelerated killing by the macrophage. In order to ascertain whether the reduced intracellularization of Ecl8&#x00394;<italic>ramR</italic> was linked to accelerated killing by macrophages, we determined the levels of extracellular non-phagocytosed bacteria in our experiments and found significantly higher numbers of recovered bacteria for Ecl8&#x00394;<italic>ramR</italic> compared to the wild type Ecl8, Ecl8&#x00394;<italic>ramA</italic> and Ecl8&#x00394;<italic>ramRA</italic> (<xref ref-type="fig" rid="ppat.1004627.g007">Fig. 7D</xref>). In previous work [<xref rid="ppat.1004627.ref034" ref-type="bibr">34</xref>], resistance to phagocytosis by <italic>K. pneumoniae</italic> has been linked to bacterial surface structures which include the capsular polysaccharide (cps). However, <italic>ugd</italic> gene transcription, representative of the <italic>cps</italic> cluster [<xref rid="ppat.1004627.ref035" ref-type="bibr">35</xref>], was not found to be altered in Ecl8, Ecl8&#x00394;<italic>ramA</italic>, Ecl8&#x00394;<italic>ramR</italic> and Ecl8&#x00394;<italic>ramRA</italic> (<xref ref-type="supplementary-material" rid="ppat.1004627.s005">S5B Fig.</xref>), consistent with the RNAseq data. Thus our results underscore that reduced phagocyte adhesion and uptake is linked to RamA-mediated alterations, particularly those associated with lipid A.</p><fig id="ppat.1004627.g007" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1004627.g007</object-id><label>Figure 7</label><caption><title>A: Attachment of <italic>K. pneumoniae</italic> Ecl8, Ecl8&#x00394;<italic>ramA</italic>, Ecl8&#x00394;<italic>ramR</italic> or Ecl8&#x02206;ramRA to murine macrophage RAW 264.7 cell line.</title><p>One-way ANOVA analyses were performed to demonstrate statistical significance. <bold>B:</bold> Microscopy to assess attachment to RAW 264.7 cell line. (i) Infection of the RAW264.7 cell line was carried out with <italic>K. pneumoniae</italic> Ecl8 (WT), Ecl8&#x00394;<italic>ramA</italic>, Ecl8&#x02206;<italic>ramR</italic> or Ecl8&#x00394;<italic>ramRA</italic> transformed with plasmid pRSMgfp. MOI was 1:100 and infections were carried out for 2 hrs. The actin cytoskeleton was stained with Acti stain 555 phalloidin (red) and host cell nuclei were stained with DAPI (blue). Images are representative of 80 fields. (ii) Graph representating mean values are derived from 3 independent experiments. One-way ANOVA analyses (P&#x0003c;0.001) were performed to demonstrate statistical significance. <bold>C:</bold> Internalisation of <italic>K. pneumoniae</italic> Ecl8, Ecl8&#x00394;<italic>ramA</italic>, Ecl8&#x00394;<italic>ramR</italic> or Ecl8&#x02206;<italic>ramRA</italic> by RAW 264.7 cells. Bacterial internalisation was assessed by the gentamicin protection assay. One-way ANOVA analyses were performed to demonstrate statistical significance. <bold>D:</bold> Enumeration of the extracellular non-phagocytosed <italic>K. pneumoniae</italic> Ecl8, Ecl8&#x00394;<italic>ramA</italic>, Ecl8&#x00394;<italic>ramR</italic> or Ecl8&#x02206;<italic>ramRA</italic>. One-way ANOVA analyses were performed to demonstrate statistical significance.</p></caption><graphic xlink:href="ppat.1004627.g007"/></fig></sec><sec id="sec002i"><title>Infection <italic>In Vivo</italic></title><p>In order to assign a broader relevance to altered <italic>Klebsiella</italic>-host interaction, we performed experiments to assess bacterial recovery using the intranasal inoculation method [<xref rid="ppat.1004627.ref036" ref-type="bibr">36</xref>] as described previously. Following a 24-hour infection of 5&#x02013;7 week old C57BL mice, organ homogenates (spleen and lung) were plated to determine bacterial counts. At 24 h post infection, bacterial recovery rates for the <italic>ramA</italic> overexpressor, Ecl8&#x00394;<italic>ramR</italic> were found to be significantly higher compared to the wild type Ecl8 or null mutant Ecl8&#x00394;<italic>ramA</italic> from the lung and spleen (<xref ref-type="fig" rid="ppat.1004627.g008">Fig. 8(A) and 8(B)</xref>). The intranasal route of infection is expected to result in the primary infection of the lung prior to dissemination to other organs. Our results demonstrate that significantly higher levels of Ecl8&#x00394;<italic>ramR</italic> is recovered from both the lung and spleen highlighting that RamR-dependent RamA overexpression, confers reduced microbial clearance and increased systemic dissemination of <italic>K. pneumoniae</italic> in an intranasal infection model.</p><fig id="ppat.1004627.g008" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1004627.g008</object-id><label>Figure 8</label><caption><title>Effect of RamA on bacterial recovery using an intranasal infection model.</title><p>Bacterial recovery (cfu/ml) was determined from lung (A) and spleen (B) homogenates following a 24h infection of 5&#x02013;7 week old, C57BL6, female mice (n = 5) using the previously described intranasal infection model. Unpaired t-test analyses were performed to demonstrate statistical significance.</p></caption><graphic xlink:href="ppat.1004627.g008"/></fig></sec></sec><sec sec-type="conclusions" id="sec003"><title>Discussion</title><p>The relevance of the MarA, SoxS, Rob, RamA and RarA regulators in microbial survival is attributed to their control of the antimicrobial resistance phenotype in a wide variety of Gram-negative bacteria [<xref rid="ppat.1004627.ref010" ref-type="bibr">10</xref>, <xref rid="ppat.1004627.ref037" ref-type="bibr">37</xref>, <xref rid="ppat.1004627.ref038" ref-type="bibr">38</xref>]. Whilst the role of RamA in reduced antibiotic susceptibility is evident from multiple studies [<xref rid="ppat.1004627.ref016" ref-type="bibr">16</xref>, <xref rid="ppat.1004627.ref017" ref-type="bibr">17</xref>, <xref rid="ppat.1004627.ref037" ref-type="bibr">37</xref>], its broader role in gene regulation is not known in <italic>Klebsiella pneumoniae</italic>. Using transcriptome profiling, we demonstrate that RamA-overexpression results in altered <italic>K. pneumoniae</italic> transcription patterns (<xref ref-type="supplementary-material" rid="ppat.1004627.s003">S3 Fig.</xref>) compared to the null mutant or wild type strain thus highlighting its wider role in gene regulation in <italic>K. pneumoniae</italic>.</p><p>Our data suggests that RamA functions largely as a transcriptional activator of gene expression, where DNA-binding (<xref ref-type="fig" rid="ppat.1004627.g004">Fig. 4B</xref>) and IVT assays (<xref ref-type="fig" rid="ppat.1004627.g004">Fig. 4C</xref>) demonstrate that this regulation is direct and likely mediated via a <italic>mar</italic>/<italic>ram</italic>-box like element [<xref rid="ppat.1004627.ref039" ref-type="bibr">39</xref>] located within the promoter region. Whilst our work is the first to demonstrate direct RamA-mediated activation of gene expression, other studies have shown that related proteins such as MarA, SoxS [<xref rid="ppat.1004627.ref040" ref-type="bibr">40</xref>] and RarA [<xref rid="ppat.1004627.ref005" ref-type="bibr">5</xref>] also exert explicit control of regulon genes. Comparative transcriptome data analyses suggests that RamA-mediated activation is dependent on regulator concentration (basal versus overexpressed, <xref ref-type="fig" rid="ppat.1004627.g002">Fig. 2</xref>) in addition to the observation that identical RamA levels induce differential levels of promoter activation as supported by our <italic>in vitro</italic> data (<xref ref-type="fig" rid="ppat.1004627.g004">Fig. 4C</xref>). The maintenance of basal <italic>ramA</italic> levels may be necessary for the <italic>K. pneumoniae</italic> stress response to a variety of agents as has been previously shown when selecting for fluoroquinolone resistant <italic>Salmonella</italic> [<xref rid="ppat.1004627.ref041" ref-type="bibr">41</xref>] <italic>or Klebsiella</italic> in a <italic>ramA</italic>-deleted strain. In <italic>K. pneumoniae</italic>, basal levels of <italic>ramA</italic> expression is maintained due to titration of the absolute repressory effects of RamR by the RamR-sRamA5 interaction (<xref ref-type="supplementary-material" rid="ppat.1004627.s002">S2 Fig.</xref>). Uniquely for tetracycline family regulators, RamR, directly interacts with the regulatory RNA, sRamA5, (<xref ref-type="fig" rid="ppat.1004627.g002">Fig. 2B</xref>) which is produced as a cleaved by-product of the primary <italic>romA</italic> transcript (<xref ref-type="fig" rid="ppat.1004627.g002">Fig. 2B</xref>). Whilst the sRamA5-RamR interaction, provides basal levels of <italic>ramA</italic> expression, <italic>ramA</italic> transcription as observed in the overexpressor, Ecl8&#x00394;<italic>ramR</italic> or clinical strains [<xref rid="ppat.1004627.ref016" ref-type="bibr">16</xref>] are linked to loss of function mutations within RamR. Consequently, our data show that the maximal changes in gene expression profiles are observed when <italic>ramA</italic> is overexpressed as in Ecl8&#x00394;<italic>ramR</italic> (<xref ref-type="supplementary-material" rid="ppat.1004627.s003">S3 Fig.</xref>). In this gene cohort, we demonstrate that RamA impacts on gene transcription linked to operons associated with efflux pumps, biofilm formation and lipid A biosynthesis (<xref ref-type="fig" rid="ppat.1004627.g003">Fig. 3</xref>, <xref ref-type="supplementary-material" rid="ppat.1004627.s009">S2 Table</xref>). Whilst it is possible that the differential regulation of these genes is not all directly linked to RamA, we demonstrate that purified RamA directly binds and activates the expression of multiple associated promoters (<xref ref-type="fig" rid="ppat.1004627.g004">Fig. 4C &#x00026; 4D</xref>).</p><p>A comparison of RamA-mediated regulation in <italic>Salmonella enterica</italic> serovar Typhimurium [<xref rid="ppat.1004627.ref004" ref-type="bibr">4</xref>] and <italic>K. pneumoniae</italic> establishes key similarities in the genes associated with the respective RamA regulons; particularly in the control of genes associated with antimicrobial resistance <italic>acrAB</italic> and <italic>ompF</italic> [<xref rid="ppat.1004627.ref004" ref-type="bibr">4</xref>, <xref rid="ppat.1004627.ref011" ref-type="bibr">11</xref>]. Additionally, RamA-dependent direct activation of <italic>acrAB</italic> is also consistent with phenotypic studies [<xref rid="ppat.1004627.ref010" ref-type="bibr">10</xref>, <xref rid="ppat.1004627.ref016" ref-type="bibr">16</xref>&#x02013;<xref rid="ppat.1004627.ref018" ref-type="bibr">18</xref>] which consistently demonstrate that <italic>ramA</italic> overexpression is linked to increased elevated efflux via <italic>acrAB</italic> and decreased outer membrane protein levels (OmpF). Given its role in conferring reduced antimicrobial susceptibility, it is perhaps not surprising that we demonstrate that RamA directly regulates other efflux related operons specifically; the AcrAB linked inner periplasmic protein, YbhT [<xref rid="ppat.1004627.ref042" ref-type="bibr">42</xref>] associated with detergent sensitivity, the Yrb operon which encodes an ABC transporter linked to the export of quinolones [<xref rid="ppat.1004627.ref027" ref-type="bibr">27</xref>] and also lipid asymmetry [<xref rid="ppat.1004627.ref030" ref-type="bibr">30</xref>]. The combined effect of the efflux or influx levels and membrane alterations associated with transport and structural variations likely contributes to the substrate range of compounds impacted by <italic>ramA</italic> overexpression (<xref ref-type="supplementary-material" rid="ppat.1004627.s010">S3 Table</xref>). However, in the absence of a functional <italic>acrAB</italic> efflux pump, RamA-overexpression does not confer reduced susceptibility to most antibiotics in <italic>K. pneumoniae</italic>. This observation is consistent with previous studies for the MarA and RarA [<xref rid="ppat.1004627.ref038" ref-type="bibr">38</xref>] proteins.</p><p>Therefore, it is likely that a functional AcrAB pump is crucial in mediating decreased antimicrobial susceptibility. However, a recent study [<xref rid="ppat.1004627.ref043" ref-type="bibr">43</xref>] also suggests that <italic>acrAB</italic> may play a role in decreased antimicrobial peptide susceptibility and increased virulence in <italic>K. pneumoniae</italic>. Our findings support this observation and further demonstrate that increased RamA levels can also mediate LPS alterations, which likely contribute towards increased survival to both polymyxins and cationic AMPs (<xref ref-type="fig" rid="ppat.1004627.g005">Fig. 5</xref>, <xref ref-type="fig" rid="ppat.1004627.g006">6</xref>).</p><p>Structurally, LPS is composed of three domains, the serovar dependent O-antigen chain, core oligosaccharide consisting of sugars and lipid A which is a phosphorylated disaccharide decorated with multiple fatty acids which anchor the LPS into the bacterial membrane [<xref rid="ppat.1004627.ref029" ref-type="bibr">29</xref>]. The endotoxic lipid A component of LPS constitutes the outermost layer of the outer membrane of Gram-negative bacteria thereby playing a critical role in host-microbe interactions in addition to promoting reduced susceptibility to cAMPs [<xref rid="ppat.1004627.ref044" ref-type="bibr">44</xref>] such as polymyxins [<xref rid="ppat.1004627.ref030" ref-type="bibr">30</xref>] and host derived factors LL-37, HBD-1 [<xref rid="ppat.1004627.ref030" ref-type="bibr">30</xref>]. Studies have shown that lipid A modifications can result in multiple outcomes such as reduced polymyxin susceptibility [<xref rid="ppat.1004627.ref045" ref-type="bibr">45</xref>] in addition to directly facilitating microbial evasion by reduced immune recognition [<xref rid="ppat.1004627.ref046" ref-type="bibr">46</xref>]. Our work suggests that the molecular basis for the modified lipid A structure is linked to the differential regulation of the biosynthesis genes e.g. <italic>lpxO</italic>, <italic>lpxL</italic>-2 and <italic>lpxC</italic> identified in this screen. Despite being constitutively produced the regulation of <italic>lpxC</italic>, <italic>lpxL</italic>-2 and <italic>lpxO</italic>, is still subject to either transcriptional or translational control [<xref rid="ppat.1004627.ref044" ref-type="bibr">44</xref>, <xref rid="ppat.1004627.ref046" ref-type="bibr">46</xref>]; generally in response to stress, where, <italic>lpxC</italic> and <italic>lpxL</italic>-2 are regulated by the two-component systems, PhoPQ and PmrAB [<xref rid="ppat.1004627.ref044" ref-type="bibr">44</xref>]. In contrast, <italic>lpxO</italic> is not subject to PhoPQ regulation in <italic>Salmonella</italic> [<xref rid="ppat.1004627.ref044" ref-type="bibr">44</xref>, <xref rid="ppat.1004627.ref046" ref-type="bibr">46</xref>].</p><p>In <italic>Salmonella</italic> Typhimurium, the modulation of LpxO levels results in the remodeling of the outer membrane which reduces the net negative charge whilst simultaneously increasing membrane integrity resulting in increased virulence [<xref rid="ppat.1004627.ref047" ref-type="bibr">47</xref>]. A similar phenotype is exhibited by the <italic>K. pneumoniae</italic> Ecl8&#x00394;<italic>ramR</italic> strain, which has altered LpxO levels (<xref ref-type="fig" rid="ppat.1004627.g008">Fig. 8</xref>). Thus we surmise that the altered host-microbe and polymyxin-microbe interactions are in part attributable to the lipid A modifications.</p><p>Macrophages represent a key innate host defence strategy against microbial infections as phagocytosis of incoming pathogens is a trigger for the inflammatory response. Our data show that <italic>ramA</italic> overexpression protects against macrophage uptake and internalization (<xref ref-type="fig" rid="ppat.1004627.g007">Fig. 7</xref>) thus providing a basis for the greater dissemination of the <italic>ramA</italic> overexpressing strain, Ecl8&#x00394;<italic>ramR</italic> in an <italic>in vivo</italic> infection model. Taken together, these RamA-linked phenotypes underscore its&#x02019; role in <italic>Klebsiella</italic> virulence and survival <italic>in vivo</italic>.</p><p>The molecular basis for phenotypes associated with reduced antimicrobial peptide susceptibility and increased virulence can be attributed to several key loci such as the <italic>acrAB</italic> pump and lipid A biosynthesis genes, <italic>lpxC</italic>, <italic>lpxL</italic>-2 and <italic>lpxO</italic>. This is supported by studies that demonstrate the involvement of <italic>acrAB</italic> [<xref rid="ppat.1004627.ref048" ref-type="bibr">48</xref>] and lipid A modifications [<xref rid="ppat.1004627.ref030" ref-type="bibr">30</xref>, <xref rid="ppat.1004627.ref044" ref-type="bibr">44</xref>] in host-microbe interactions. However to definitively pinpoint the exact contribution of the lipid A biosynthetic genes or <italic>acrAB</italic> to phenotypes associated with host-pathogen interactions would require the deletion of genes encoding <italic>lpxC</italic> [<xref rid="ppat.1004627.ref049" ref-type="bibr">49</xref>], <italic>lpxL</italic>-2 and <italic>lpxO</italic> [<xref rid="ppat.1004627.ref050" ref-type="bibr">50</xref>], <italic>acrAB</italic> individually or in combination with <italic>ramA</italic> overexpression. We note that previous studies [<xref rid="ppat.1004627.ref032" ref-type="bibr">32</xref>, <xref rid="ppat.1004627.ref050" ref-type="bibr">50</xref>] have shown that strains deleted for these genes, result in avirulent microbes and as such, this phenotype would obscure any RamA-associated effects. Nevertheless, our work is first to demonstrate that firstly, RamA functions as an alternate regulator of certain lipid A biosynthesis genes and secondly, these alterations perturb microbe-host interaction.</p><p>The significance of our findings lies in the broader implications of RamA-mediated regulation in Enterobacteriaceae. In this work, we describe roles for RamA in both protection against antibiotic challenge but also against the innate host immune response thus resulting in <italic>Klebsiellae</italic> that are less susceptible to antibiotics and simultaneously more virulent. Notably, our findings highlight that RamA mediated overexpression via both increased <italic>acrAB</italic> expression and lipid A alterations can result in reduced susceptibility to the last line drugs e.g. tigecycline and polymyxins. This highlights the broader consequences in selecting for <italic>ramA</italic> overexpression in <italic>K. pneumoniae</italic> or other members of <italic>Enterobacteriaceae</italic>. Finally, our study underscores and highlights the importance of intrinsic proteins such as RamA, which regulate survival strategies in <italic>K. pneumoniae</italic> and likely other Enterobacteriaceae, specifically in priming the microbial population in surviving drug and host immune pressure. This proposes the notion where microbial immune evasive strategies contribute to the development and persistence of antimicrobial resistance.</p></sec><sec sec-type="materials|methods" id="sec004"><title>Materials and Methods</title><sec id="sec004a"><title>Growth Conditions</title><p>Bacteria (<xref ref-type="table" rid="ppat.1004627.t001">Table 1</xref>) were cultured in Luria-Bertani (LB) medium (10 g/L tryptone, 5 g/L yeast extract, 10 g/L NaCl). Typically, a strain was first grown on an LB plate at 37&#x000b0;C from frozen -80&#x000b0;C stocks. A single colony was picked and inoculated into 5 ml of LB and incubated in a 37&#x000b0;C shaker overnight. A 1 in 100 dilution was made in LB and incubated in a 37&#x000b0;C shaker until the OD<sub>600</sub> reached 0.6 unless otherwise stated. Antibiotics such as ampicillin (100 &#x000b5;g/ml) and chloramphenicol (20 &#x000b5;g/ml) were added as required.</p><table-wrap id="ppat.1004627.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1004627.t001</object-id><label>Table 1</label><caption><title>Strains used in this study.</title></caption><alternatives><graphic id="ppat.1004627.t001g" xlink:href="ppat.1004627.t001"/><table frame="hsides" rules="rows" border="0"><colgroup span="1"><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"><bold>Strains</bold></th><th align="left" rowspan="1" colspan="1"><bold>Description</bold></th><th align="left" rowspan="1" colspan="1"><bold>Ref</bold></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Ecl8</td><td align="left" rowspan="1" colspan="1">Wild type <italic>K. pneumoniae</italic></td><td align="left" rowspan="1" colspan="1">[<xref rid="ppat.1004627.ref059" ref-type="bibr">59</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Ecl8&#x00394;<italic>ramA</italic></td><td align="left" rowspan="1" colspan="1"><italic>K. pneumoniae</italic> deleted of <italic>ramA</italic></td><td align="left" rowspan="1" colspan="1">[<xref rid="ppat.1004627.ref016" ref-type="bibr">16</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Ecl8&#x00394;<italic>ramR</italic></td><td align="left" rowspan="1" colspan="1"><italic>K. pneumoniae</italic> deleted of <italic>ramR</italic></td><td align="left" rowspan="1" colspan="1">[<xref rid="ppat.1004627.ref016" ref-type="bibr">16</xref>]</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="sec004b"><title>Antimicrobial Susceptibility and Peptide Survival Assay</title><p>The assay was as described previously by Moranta <italic>et al</italic> [<xref rid="ppat.1004627.ref051" ref-type="bibr">51</xref>]. Briefly, bacteria were grown at 37&#x000b0;C in 5 ml LB medium, harvested (5,000 &#x000d7; g, 15 min, 5&#x000b0;C) and washed thrice with phosphate-buffered saline (PBS). A suspension containing approximately 10<sup>5</sup> CFU/ml was prepared in 10 mM PBS (pH 6.5), 1% tryptone soy broth (TSB; Oxoid), and 100 mM NaCl. Aliquots (5 &#x003bc;l) of this suspension were mixed in tubes with various concentrations of polymyxin B, colistin (0.064 &#x000b5;g/ml to 0.256 &#x000b5;g/ml) and LL-37 (32 &#x000b5;g/ml to 85.3 &#x000b5;g/ml) to a final volume of 30 &#x000b5;l. Following incubation for an hour at 37&#x000b0;C with polymyxin B (Sigma, UK), colistin (Sigma, UK) and LL-37 (Sigma, UK) the samples were diluted 1:10 with PBS prior to plating (100 &#x003bc;l) on LB agar. Colony counts were determined after overnight incubation, where results are expressed as percentages of the colony count of bacteria that were not exposed to the antibiotics or the antimicrobial peptide. Sensitivity profiles of the different mutants using the phenotypic microarray analyses were determined described in <xref ref-type="supplementary-material" rid="ppat.1004627.s007">S1 Text</xref>.</p></sec><sec id="sec004c"><title>RNA Extraction, RNA-Seq Sample Preparation and Sequencing</title><p>Overnight cultures of strains Ecl8, Ecl8&#x00394;<italic>ramA</italic>, Ecl8&#x00394;<italic>ramR</italic> were inoculated (1/100 dilution) into LB media and incubated at 37 &#x000ba;C with vigorous shaking. Cell pellets were harvested at OD<sub>600</sub> = 0.6 and RNA was extracted using the RNAeasy Extraction Kit (Qiagen, Hilden, Germany), which enriches for RNA molecules larger than 200 nucleotides. No depletion of ribosomal RNA was carried out prior to the synthesis of single-stranded cDNA (sscDNA) as previously reported [<xref rid="ppat.1004627.ref052" ref-type="bibr">52</xref>]. RNAseq DNA libraries were constructed as previously described [<xref rid="ppat.1004627.ref053" ref-type="bibr">53</xref>]. For RNAseq, independent biological samples in triplicate were assessed for each strain. The resulting sscDNA libraries were sequenced in an Illumina HISeq 2000 sequencer. An average of 0.715 Gb of sequence data was obtained per sample, in 75 bp paired reads (Details of RNAseq analyses are outlined in <xref ref-type="supplementary-material" rid="ppat.1004627.s007">S1 Text</xref>). The RNAseq read data has been deposited under the ENA data repository and ArrayExpress with the accession numbers ERP001994 and E-ERAD-122, respectively.</p><p>RNA for quantitative Real-Time PCR experiments was extracted from <italic>K. pneumoniae</italic> strains (<xref ref-type="table" rid="ppat.1004627.t001">Table 1</xref>) using the TRIzol extraction method [<xref rid="ppat.1004627.ref016" ref-type="bibr">16</xref>]. Briefly, cells were grown to mid-log phase (OD<sub>600</sub> = 0.6) at 37 &#x000ba;C with shaking and then harvested by centrifugation at 3000g (PK121R, ALC) at 4 &#x000ba;C. The cell pellet was then resuspended in TRIzol reagent (Invitrogen, Paisley, UK) and chloroform prior to centrifugation to separate the phases. The upper phase was then precipitated using 3 M sodium acetate, glycogen (5 mg/ml), and 100% ethanol.</p><p>Both RNA preparations were washed and resuspended in 50 &#x000b5;l DEPC treated water. RNA was treated with TurboDNase to remove DNA contamination (Ambion, New York, USA). All samples were assessed for RNA integrity and quantification using both the Bioanalyzer 2100 RNA nanochip (Agilent, UK) and the ND-1000 (Nanodrop Technologies) [<xref rid="ppat.1004627.ref004" ref-type="bibr">4</xref>]. Only those samples with integrity level 9 were taken forward for library construction or qPCR analyses.</p></sec><sec id="sec004d"><title>Quantitative Real-Time PCR (qPCR)</title><p>In order to validate the RNAseq data, quantitative Real-Time PCR experiments were undertaken. After the removal of contaminating DNA, cDNA synthesis was generated using the AffinityScript cDNA synthesis kit (Agilent, UK). Gene specific primers (<xref ref-type="supplementary-material" rid="ppat.1004627.s011">S4 Table</xref>) were designed using the Primer3 (<ext-link ext-link-type="uri" xlink:href="http://frodo.wi.mit.edu/">http://frodo.wi.mit.edu/</ext-link>) software and were tested to produce standard curves with amplification efficiencies ranging from 95&#x02013;110%. qPCR analyses using the locked nucleic acid probe is detailed in <xref ref-type="supplementary-material" rid="ppat.1004627.s007">S1 Text</xref>. Quantitative Real Time RT-PCR (RT-PCR) was performed using the synthesized cDNA with gene specific primers using the Brilliant III Ultra-fast SYBR Green Kit (Agilent, UK) in the Agilent Mx3005P. All data were analyzed using Agilent MxPro software, which is based on the efficiency corrected method (Pfaffl) of comparative quantification that utilizes the &#x00394;&#x00394;Ct approach, also taking into account primer efficiency. The relative fold increases in expression levels were determined by firstly normalizing gene expression levels to 16S rDNA and using either Ecl8 or Ecl8&#x02206;<italic>ramA</italic> as calibrators. All comparative analyses were done using the MxPro software (Agilent, UK).</p></sec><sec id="sec004e"><title>DNA EMSA</title><p>DNA fragments that represent the promoter regions of the genes that were differentially regulated in the presence or absence of RamA or RamR were subjected to the electrophoretic gel shift mobility assay (EMSA) as described previously [<xref rid="ppat.1004627.ref054" ref-type="bibr">54</xref>]. Briefly, DNA templates ranging from 250&#x02013;150bp upstream of the start site were produced by PCR, and purified by StrataPrep PCR Purification kits (Agilent UK). The purified templates were end-labelled with [&#x003b3;<sup>32</sup>P]-ATP by T4 Kinase (New England Biolabs, USA). The unincorporated, labelled ATP was removed using Biospin P6 spin columns (Biorad, UK) as per manufacturer&#x02019;s instructions. Purified RamA was extracted from the recombinant pET<italic>ramA</italic> construct using metal chelation chromatography on superflow nickel / nitrilotriacetate agarose (Qiagen, Germany) (James Hastie, Dundee University). His-tagged RamA (200 nM) and labelled DNA (2 nM) were mixed in binding buffer (125 mM Tris-HCl, 250 mM KCl, 5 mM DTT 5% glycerol) and incubated on ice for 15 min prior to electrophoresis at 75 V on a prechilled 7.5% native polyacrylamide gel in 1 &#x000d7; TBE buffer.</p></sec><sec id="sec004f"><title>Transcription <italic>In Vitro</italic></title><p>Transcription (IVT) experiments were performed as described previously [<xref rid="ppat.1004627.ref055" ref-type="bibr">55</xref>]. Briefly 5 &#x000d7; IVT Buffer, 2 nM PCR product of the test and control (<italic>E. coli gnd</italic> [<xref rid="ppat.1004627.ref056" ref-type="bibr">56</xref>]) promoters, RNA polymerase, RNAseOUT (Invitrogen, UK) was incubated for 15 minutes at 37&#x000b0;C prior to the addition of the transcription mix containing &#x000d7; 5 IVT buffer (50 mM Tris-HCl, 0.1 mM EDTA, 3 mM magnesium acetate, 0.1 mM dithiothreitol, 20 mM sodium chloride, and 250 &#x003bc;g/ml bovine serum albumin at pH 7.8), heparin (1.2 &#x000b5;g/ml), NTPS, and &#x003b1;<sup>32</sup>P-UTP (Perkin Elmer, UK). The reaction was stopped 5 minutes later followed by the addition of Gel loading buffer II (Ambion, UK). The resulting products were electrophoresed on a 7% polyacrylamide / 8 M urea gel. Quantification was determined by densitometric analysis using Fujifilm Multigauge Software where an increase or decrease in transcription levels is after normalization to the endogenous <italic>gnd</italic> levels and calibration to the no protein control.</p></sec><sec id="sec004g"><title>Cell Culture</title><p>Murine RAW 264.7 macrophage cells (obtained from ATCC TIB-71) were cultured in Dulbecco&#x02019;s Modified Eagle Medium (PAA, UK) supplemented with 10% endotoxin-free foetal bovine serum (PAA, UK) and penicillin and streptomycin (Invitrogen, UK) in 75-cm<sup>2</sup> culture flasks in 5% CO<sub>2</sub> for 24 h until subconfluent. Twelve well tissue culture plates were seeded with 5 &#x000d7; 10<sup>5</sup> cells per well and viability determined using trypan blue exclusion.</p></sec><sec id="sec004h"><title>Bacterial Adhesion and Internalisation Assays</title><p>Bacterial adhesion and internalization experiments were performed as described previously [<xref rid="ppat.1004627.ref057" ref-type="bibr">57</xref>, <xref rid="ppat.1004627.ref058" ref-type="bibr">58</xref>]. For the adhesion assays, RAW cells were washed with PBS and incubated for 2 h at 37&#x000b0;C in 5% CO<sub>2</sub> with a suspension of 5 &#x000d7; 10<sup>7</sup> bacterial cells in DMEM medium alone. After incubation, wells were washed five times with PBS and adherent bacteria were released by addition of 0.5% Triton X-100 (Sigma, UK). Bacterial colonies were quantified by plating appropriate dilutions on LB agar plates. In the internalization assays, after the incubation of the RAW cells with the bacterial suspension, wells were washed twice with PBS and then incubated for 2 h with fresh DMEM medium containing gentamicin (100 &#x000b5;g/ml) to eliminate extracellular bacteria. After the incubation, an aliquot of the medium was plated to confirm killing of extracellular bacteria and the gentamicin-containing medium was washed again. RAW cells were lysed and intracellular bacteria were quantified as described above. To estimate levels of extracellular bacteria, the infection of the RAW cells was carried out as described previously for the adhesion assay. After incubation, the media with the non-phagocytosed extracellular bacteria was collected and quantified by plating appropriate dilutions on LB agar plates. All microscopy images were generated as outlined in <xref ref-type="supplementary-material" rid="ppat.1004627.s007">S1 Text</xref>.</p></sec><sec id="sec004i"><title>Ethics Statement</title><p>All mouse experiments were performed under the control of the UK Home Office legislation in accordance with the terms of the Project license (PPL2700) granted for this work under the Animals (Scientific Procedures) Act 1986 in addition to receiving formal approval of the document through Queen&#x02019;s University Belfast Animal Welfare and Ethical Review Body.</p></sec><sec id="sec004j"><title>Infection <italic>In Vivo</italic></title><p>Overnight bacterial cultures were washed three times in sterile endotoxin free PBS. The bacteria was resuspended to an optical density of 0.2 and 20 &#x003bc;l (&#x0223c; 5 &#x000d7; 10<sup>7</sup> CFU/animal) and administered to anaesthetised 5&#x02013;7 week old weight watched Harlan C57BL6 mice (n = 5 per group) using the intranasal inoculation method [<xref rid="ppat.1004627.ref036" ref-type="bibr">36</xref>]. In order to ensure maximal delivery of the bacterial inoculation into the lungs the animals were held in a perpendicular position until cessation of laboured breathing. 24 h post inoculation the mice were sacrificed by lethal pentabarbitol injection. Perfused lungs and spleen were harvested and resuspended in 1 ml of sterile PBS. Following mechanical homogenisation dilutions were plated on LB agar plates and incubated at 37&#x000b0;C to establish the CFU/ml.</p></sec></sec><sec sec-type="supplementary-material" id="sec005"><title>Supporting Information</title><supplementary-material content-type="local-data" id="ppat.1004627.s001"><label>S1 Fig</label><caption><title>Transcriptional start sites (TSS) of <italic>ramR</italic>, sRamA5 and <italic>romA</italic> determined by 5&#x02019; RACE.</title><p>Capitalized triplets are start codons of either <italic>ramR</italic> or <italic>romA</italic>. Bold capital letters indicate the primary and secondary TSS sites for <italic>ramR</italic> or <italic>sRamA5</italic> and <italic>romA</italic>. The primary and secondary TSSs of <italic>ramR</italic> are indicated with a black and grey arrow respectively. The shaded segments are the inverted repeat (IR) sequences recognized by the RamR protein. The sequences indicated by the dotted underlined fragment (RL) and the single underlined fragment (RH) were used in eGFP analysis. The numbering system is based on the &#x0201c;t&#x0201d; prior to <italic>romA</italic>&#x02019;s start codon ATG as the -1.</p><p>(TIF)</p></caption><media xlink:href="ppat.1004627.s001.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1004627.s002"><label>S2 Fig</label><caption><title>Fluorescence reporter analysis for RH promoter activity and its repression by RamR.</title><p>Where indicated DH5&#x003b1; contained both the pKC026 (containing either the RH fragments) and pBR322<italic>ramR</italic> plasmid. DH5&#x003b1; haboring both pKC026 and pBR322 is taken as a negative control and the RH fragment containing pKC026 with pBR322 only taken as the baseline control.</p><p>(TIF)</p></caption><media xlink:href="ppat.1004627.s002.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1004627.s003"><label>S3 Fig</label><caption><title>Kolmogorov-Smirnov 2-sample test.</title><p>The plots show the sample distribution of log<sub>2</sub>-transformed basemean values from the RNAseq experiment for Ecl8, Ecl8&#x00394;<italic>ramA</italic> and Ecl8&#x00394;<italic>ramR</italic>. The D value (the largest vertical distance between two curves) between Ecl8 and Ecl8&#x00394;<italic>ramA</italic> is 0.046; the one between Ecl8 and Ecl8&#x00394;ramR is 0.067, and the one between Ecl8&#x00394;<italic>ramA</italic> and Ecl8&#x00394;<italic>ramR</italic> is 0.036. All of the distributions are significantly different from each other (p &#x0003c; 0.001).</p><p>(TIF)</p></caption><media xlink:href="ppat.1004627.s003.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1004627.s004"><label>S4 Fig</label><caption><title>Coverage plot for the antisense transcription of BN373_16241 in Ecl8&#x00394;<italic>ramA</italic> and Ecl8&#x00394;<italic>ramR</italic>.</title><p>The coverage plot is visualized with Artemis Genome Browser using the Ecl8 genome as a reference. Window size is set at 3. One representative coverage plot of Ecl8&#x00394;<italic>ramA</italic> and Ecl8&#x00394;<italic>ramR</italic> is shown here. The borders of the coding region of BN373_16241 are marked by vertical black bars in the coverage plot. The green and red curves within the borders represent the antisense and sense transcription of BN373_16241 respectively.</p><p>(TIF)</p></caption><media xlink:href="ppat.1004627.s004.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1004627.s005"><label>S5 Fig</label><caption><title>A: Quantitative real-time RT-PCR analyses of <italic>romA</italic> and <italic>ramA</italic> gene expression levels in Ecl8&#x00394;<italic>ramR</italic>.</title><p>B: Gene expression of <italic>ugd</italic>, <italic>pagP</italic> genes in different <italic>K. pneumoniae</italic> strains. All qPCR experiments were performed as outlined in <xref ref-type="sec" rid="sec004">materials and methods</xref>. Expression levels were normalized to 16S levels, and fold change values were generated by calibrating against Ecl8&#x02206;ramA. All data is a mean of 3 experiments.</p><p>(TIF)</p></caption><media xlink:href="ppat.1004627.s005.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1004627.s006"><label>S6 Fig</label><caption><title>Heat map of the Biolog phenotype of Ecl8, Ecl8&#x00394;<italic>ramA</italic> and Ecl8&#x00394;<italic>ramR</italic>.</title><p>Biolog analyses of the wild type <italic>K. pneumoniae</italic> Ecl8, Ecl8&#x00394;<italic>ramA</italic> and <italic>K. pneumoniae</italic> Ecl8&#x00394;<italic>ramR</italic> using PM1&#x02013;20 plates.</p><p>(TIF)</p></caption><media xlink:href="ppat.1004627.s006.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1004627.s007"><label>S1 Text</label><caption><title>Supporting Materials and Methods.</title><p>(DOCX)</p></caption><media xlink:href="ppat.1004627.s007.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1004627.s008"><label>S1 Table</label><caption><title>Raw mapped RNAseq data.</title><p>(XLS)</p></caption><media xlink:href="ppat.1004627.s008.xls"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1004627.s009"><label>S2 Table</label><caption><title>List of differentially expressed genes in the pairwise comparison with COG analyses.</title><p>(XLSX)</p></caption><media xlink:href="ppat.1004627.s009.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1004627.s010"><label>S3 Table</label><caption><title>Biolog phenotypic profile of the <italic>K. pneumoniae</italic> stains.</title><p>(XLSX)</p></caption><media xlink:href="ppat.1004627.s010.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1004627.s011"><label>S4 Table</label><caption><title>List of primers used in this study.</title><p>(XLSX)</p></caption><media xlink:href="ppat.1004627.s011.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>The authors acknowledge reagent, technical support and advice provided by Nuala Tipping, Tom Gardiner, Eimear Linehan and Denise Fitzgerald, Centre for Infection and Immunity, QUB, for microscopy reagents. We thank Dr. Nicola Holden, Prof. Jay Hinton for the plasmid pRSMgfp+, Dr. Bhargav Mitra for the program code in Matlab for microscopy data analyses and Prof. N. Thomson for facilitating the transcriptome analyses.</p></ack><ref-list><title>References</title><ref id="ppat.1004627.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Barbosa</surname><given-names>TM</given-names></name>, <name><surname>Levy</surname><given-names>SB</given-names></name> (<year>2000</year>) <article-title>Differential Expression of Over 60 Chromosomal Genes in <italic>Escherichia coli</italic> by Constitutive Expression of MarA</article-title>. <source>J Bacteriol</source>
<volume>182</volume>: <fpage>3467</fpage>&#x02013;<lpage>3474</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/JB.182.12.3467-3474.2000">10.1128/JB.182.12.3467-3474.2000</ext-link></comment>
<?supplied-pmid 10852879?><pub-id pub-id-type="pmid">10852879</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref002"><label>2</label><mixed-citation publication-type="journal">
<name><surname>Pomposiello</surname><given-names>PJ</given-names></name>, <name><surname>Bennik</surname><given-names>MH</given-names></name>, <name><surname>Demple</surname><given-names>B</given-names></name> (<year>2001</year>) <article-title>Genome-wide Transcriptional Profiling of the <italic>Escherichia coli</italic> Responses to Superoxide Stress and Sodium Salicylate</article-title>. <source>J Bacteriol</source>
<volume>183</volume>: <fpage>3890</fpage>&#x02013;<lpage>3902</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/JB.183.13.3890-3902.2001">10.1128/JB.183.13.3890-3902.2001</ext-link></comment>
<?supplied-pmid 11395452?><pub-id pub-id-type="pmid">11395452</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref003"><label>3</label><mixed-citation publication-type="journal">
<name><surname>Bennik</surname><given-names>MH</given-names></name>, <name><surname>Pomposiello</surname><given-names>PJ</given-names></name>, <name><surname>Thorne</surname><given-names>DF</given-names></name>, <name><surname>Demple</surname><given-names>B</given-names></name> (<year>2000</year>) <article-title>Defining a rob regulon in <italic>Escherichia coli</italic> by using transposon mutagenesis</article-title>. <source>J Bacteriol</source>
<volume>182</volume>: <fpage>3794</fpage>&#x02013;<lpage>3801</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/JB.182.13.3794-3801.2000">10.1128/JB.182.13.3794-3801.2000</ext-link></comment>
<?supplied-pmid 10850996?><pub-id pub-id-type="pmid">10850996</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref004"><label>4</label><mixed-citation publication-type="journal">
<name><surname>Bailey</surname><given-names>AM</given-names></name>, <name><surname>Ivens</surname><given-names>A</given-names></name>, <name><surname>Kingsley</surname><given-names>R</given-names></name>, <name><surname>Cottell</surname><given-names>JL</given-names></name>, <name><surname>Wain</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>RamA, a member of the AraC/XylS family, influences both virulence and efflux in <italic>Salmonella enterica</italic> serovar <italic>Typhimurium</italic></article-title>. <source>J Bacteriol</source>
<volume>192</volume>: <fpage>1607</fpage>&#x02013;<lpage>1616</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/JB.01517-09">10.1128/JB.01517-09</ext-link></comment>
<?supplied-pmid 20081028?><pub-id pub-id-type="pmid">20081028</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref005"><label>5</label><mixed-citation publication-type="journal">
<name><surname>De Majumdar</surname><given-names>S</given-names></name>, <name><surname>Veleba</surname><given-names>M</given-names></name>, <name><surname>Finn</surname><given-names>S</given-names></name>, <name><surname>Fanning</surname><given-names>S</given-names></name>, <name><surname>Schneiders</surname><given-names>T</given-names></name> (<year>2013</year>) <article-title>Elucidating the regulon of multidrug resistance regulator RarA in <italic>Klebsiella pneumoniae</italic></article-title>. <source>Antimicrob Agents Chemother</source>
<volume>57</volume>: <fpage>1603</fpage>&#x02013;<lpage>1609</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/AAC.01998-12">10.1128/AAC.01998-12</ext-link></comment>
<?supplied-pmid 23318802?><pub-id pub-id-type="pmid">23318802</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref006"><label>6</label><mixed-citation publication-type="journal">
<name><surname>Martin</surname><given-names>RG</given-names></name>, <name><surname>Rosner</surname><given-names>JL</given-names></name> (<year>2001</year>) <article-title>The AraC transcriptional activators</article-title>. <source>Curr Opin Microbiol</source>
<volume>4</volume>: <fpage>132</fpage>&#x02013;<lpage>137</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S1369-5274(00)00178-8">10.1016/S1369-5274(00)00178-8</ext-link></comment>
<?supplied-pmid 11282467?><pub-id pub-id-type="pmid">11282467</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref007"><label>7</label><mixed-citation publication-type="journal">
<name><surname>Piddock</surname><given-names>LJ</given-names></name> (<year>2006</year>) <article-title>Multidrug-resistance efflux pumps&#x02014;not just for resistance</article-title>. <source>Nat Rev Microbiol</source>
<volume>4</volume>: <fpage>629</fpage>&#x02013;<lpage>636</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrmicro1464">10.1038/nrmicro1464</ext-link></comment>
<?supplied-pmid 16845433?><pub-id pub-id-type="pmid">16845433</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref008"><label>8</label><mixed-citation publication-type="journal">
<name><surname>Dangi</surname><given-names>B</given-names></name>, <name><surname>Pelupessey</surname><given-names>P</given-names></name>, <name><surname>Martin</surname><given-names>RG</given-names></name>, <name><surname>Rosner</surname><given-names>JL</given-names></name>, <name><surname>Louis</surname><given-names>JM</given-names></name>, <etal>et al</etal> (<year>2001</year>) <article-title>Structure and Dynamics of MarA-DNA Complexes: An NMR Investigation</article-title>. <source>J Mol Biol</source>
<volume>314</volume>: <fpage>113</fpage>&#x02013;<lpage>127</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1006/jmbi.2001.5106">10.1006/jmbi.2001.5106</ext-link></comment>
<?supplied-pmid 11724537?><pub-id pub-id-type="pmid">11724537</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref009"><label>9</label><mixed-citation publication-type="journal">
<name><surname>Griffith</surname><given-names>KL</given-names></name>, <name><surname>Shah</surname><given-names>IM</given-names></name>, <name><surname>Myers</surname><given-names>TE</given-names></name>, <name><surname>O&#x02019;Neill</surname><given-names>MC</given-names></name>, <name><surname>Wolf</surname><given-names>RE</given-names><suffix>Jr.</suffix></name> (<year>2002</year>) <article-title>Evidence for &#x0201c;pre-recruitment&#x0201d; as a new mechanism of transcription activation in <italic>Escherichia coli</italic>: the large excess of SoxS binding sites per cell relative to the number of SoxS molecules per cell</article-title>. <source>Biochem Biophys Res Commun</source>
<volume>291</volume>: <fpage>979</fpage>&#x02013;<lpage>986</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1006/bbrc.2002.6559">10.1006/bbrc.2002.6559</ext-link></comment>
<?supplied-pmid 11866462?><pub-id pub-id-type="pmid">11866462</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref010"><label>10</label><mixed-citation publication-type="journal">
<name><surname>Alekshun</surname><given-names>MN</given-names></name>, <name><surname>Levy</surname><given-names>SB</given-names></name> (<year>1997</year>) <article-title>Regulation of Chromosomally Mediated Multiple Antibiotic Resistance: the <italic>mar</italic> Regulon</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>41</volume>: <fpage>2067</fpage>&#x02013;<lpage>2075</lpage>. <?supplied-pmid 9333027?><pub-id pub-id-type="pmid">9333027</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref011"><label>11</label><mixed-citation publication-type="journal">
<name><surname>Zheng</surname><given-names>J</given-names></name>, <name><surname>Tian</surname><given-names>F</given-names></name>, <name><surname>Cui</surname><given-names>S</given-names></name>, <name><surname>Song</surname><given-names>J</given-names></name>, <name><surname>Zhao</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Differential gene expression by RamA in ciprofloxacin-resistant <italic>Salmonella</italic> Typhimurium</article-title>. <source>PLoS One</source>
<volume>6</volume>: <fpage>e22161</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0022161">10.1371/journal.pone.0022161</ext-link></comment>
<?supplied-pmid 21811569?><pub-id pub-id-type="pmid">21811569</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref012"><label>12</label><mixed-citation publication-type="journal">
<name><surname>Hung</surname><given-names>DT</given-names></name>, <name><surname>Shakhnovich</surname><given-names>EA</given-names></name>, <name><surname>Pierson</surname><given-names>E</given-names></name>, <name><surname>Mekalanos</surname><given-names>JJ</given-names></name> (<year>2005</year>) <article-title>Small-molecule inhibitor of <italic>Vibrio cholerae</italic> virulence and intestinal colonization</article-title>. <source>Science</source>
<volume>310</volume>: <fpage>670</fpage>&#x02013;<lpage>674</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.1116739">10.1126/science.1116739</ext-link></comment>
<?supplied-pmid 16223984?><pub-id pub-id-type="pmid">16223984</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref013"><label>13</label><mixed-citation publication-type="journal">
<name><surname>Casaz</surname><given-names>P</given-names></name>, <name><surname>Garrity-Ryan</surname><given-names>LK</given-names></name>, <name><surname>McKenney</surname><given-names>D</given-names></name>, <name><surname>Jackson</surname><given-names>C</given-names></name>, <name><surname>Levy</surname><given-names>SB</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>MarA, SoxS and Rob function as virulence factors in an <italic>Escherichia coli</italic> murine model of ascending pyelonephritis</article-title>. <source>Microbiology</source>
<volume>152</volume>: <fpage>3643</fpage>&#x02013;<lpage>3650</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1099/mic.0.2006/000604-0">10.1099/mic.0.2006/000604-0</ext-link></comment>
<?supplied-pmid 17159217?><pub-id pub-id-type="pmid">17159217</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref014"><label>14</label><mixed-citation publication-type="journal">
<name><surname>Chollet</surname><given-names>R</given-names></name>, <name><surname>Chevalier</surname><given-names>J</given-names></name>, <name><surname>Bollet</surname><given-names>C</given-names></name>, <name><surname>Pages</surname><given-names>JM</given-names></name>, <name><surname>Davin-Regli</surname><given-names>A</given-names></name> (<year>2004</year>) <article-title>RamA is an alternate activator of the multidrug resistance cascade in <italic>Enterobacter aerogenes</italic></article-title>. <source>Antimicrob Agents Chemother</source>
<volume>48</volume>: <fpage>2518</fpage>&#x02013;<lpage>2523</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/AAC.48.7.2518-2523.2004">10.1128/AAC.48.7.2518-2523.2004</ext-link></comment>
<?supplied-pmid 15215103?><pub-id pub-id-type="pmid">15215103</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref015"><label>15</label><mixed-citation publication-type="journal">
<name><surname>Yassien</surname><given-names>MA</given-names></name>, <name><surname>Ewis</surname><given-names>HE</given-names></name>, <name><surname>Lu</surname><given-names>CD</given-names></name>, <name><surname>Abdelal</surname><given-names>AT</given-names></name> (<year>2002</year>) <article-title>Molecular cloning and characterization of the <italic>Salmonella enterica</italic> Serovar Paratyphi B rma Gene, which confers multiple drug resistance in <italic>Escherichia coli</italic></article-title>. <source>Antimicrob Agents Chemother</source>
<volume>46</volume>: <fpage>360</fpage>&#x02013;<lpage>366</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/AAC.46.2.360-366.2002">10.1128/AAC.46.2.360-366.2002</ext-link></comment>
<?supplied-pmid 11796342?><pub-id pub-id-type="pmid">11796342</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref016"><label>16</label><mixed-citation publication-type="journal">
<name><surname>Rosenblum</surname><given-names>R</given-names></name>, <name><surname>Khan</surname><given-names>E</given-names></name>, <name><surname>Gonzalez</surname><given-names>G</given-names></name>, <name><surname>Hasan</surname><given-names>R</given-names></name>, <name><surname>Schneiders</surname><given-names>T</given-names></name> (<year>2011</year>) <article-title>Genetic regulation of the <italic>ramA</italic> locus and its expression in clinical isolates of <italic>Klebsiella pneumoniae</italic></article-title>. <source>Int J Antimicrob Agents</source>
<volume>38</volume>: <fpage>39</fpage>&#x02013;<lpage>45</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ijantimicag.2011.02.012">10.1016/j.ijantimicag.2011.02.012</ext-link></comment>
<?supplied-pmid 21514798?><pub-id pub-id-type="pmid">21514798</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref017"><label>17</label><mixed-citation publication-type="journal">
<name><surname>Hentschke</surname><given-names>M</given-names></name>, <name><surname>Wolters</surname><given-names>M</given-names></name>, <name><surname>Sobottka</surname><given-names>I</given-names></name>, <name><surname>Rohde</surname><given-names>H</given-names></name>, <name><surname>Aepfelbacher</surname><given-names>M</given-names></name> (<year>2010</year>) <article-title><italic>ramR</italic> mutations in clinical isolates of <italic>Klebsiella pneumoniae</italic> with reduced susceptibility to Tigecycline</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>54</volume>: <fpage>2720</fpage>&#x02013;<lpage>2723</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/AAC.00085-10">10.1128/AAC.00085-10</ext-link></comment>
<?supplied-pmid 20350947?><pub-id pub-id-type="pmid">20350947</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref018"><label>18</label><mixed-citation publication-type="journal">
<name><surname>Abouzeed</surname><given-names>YM</given-names></name>, <name><surname>Baucheron</surname><given-names>S</given-names></name>, <name><surname>Cloeckaert</surname><given-names>A</given-names></name> (<year>2008</year>) <article-title><italic>ramR</italic> mutations involved in efflux-mediated multidrug resistance in <italic>Salmonella enterica</italic> serovar Typhimurium</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>52</volume>: <fpage>2428</fpage>&#x02013;<lpage>2434</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/AAC.00084-08">10.1128/AAC.00084-08</ext-link></comment>
<?supplied-pmid 18443112?><pub-id pub-id-type="pmid">18443112</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref019"><label>19</label><mixed-citation publication-type="journal">
<name><surname>Yamasaki</surname><given-names>S</given-names></name>, <name><surname>Nikaido</surname><given-names>E</given-names></name>, <name><surname>Nakashima</surname><given-names>R</given-names></name>, <name><surname>Sakurai</surname><given-names>K</given-names></name>, <name><surname>Fujiwara</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>The crystal structure of multidrug-resistance regulator RamR with multiple drugs</article-title>. <source>Nat Commun</source>
<volume>4</volume>: <fpage>2078</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ncomms3078">10.1038/ncomms3078</ext-link></comment>
<?supplied-pmid 23800819?><pub-id pub-id-type="pmid">23800819</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref020"><label>20</label><mixed-citation publication-type="journal">
<name><surname>Martin</surname><given-names>RG</given-names></name>, <name><surname>Bartlett</surname><given-names>ES</given-names></name>, <name><surname>Rosner</surname><given-names>JL</given-names></name>, <name><surname>Wall</surname><given-names>ME</given-names></name> (<year>2008</year>) <article-title>Activation of the <italic>Escherichia coli marA</italic>/<italic>soxS</italic>/<italic>rob</italic> regulon in response to transcriptional activator concentration</article-title>. <source>J Mol Biol</source>
<volume>380</volume>: <fpage>278</fpage>&#x02013;<lpage>284</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jmb.2008.05.015">10.1016/j.jmb.2008.05.015</ext-link></comment>
<?supplied-pmid 18514222?><pub-id pub-id-type="pmid">18514222</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref021"><label>21</label><mixed-citation publication-type="journal">
<name><surname>Ruzin</surname><given-names>A</given-names></name>, <name><surname>Visalli</surname><given-names>MA</given-names></name>, <name><surname>Keeney</surname><given-names>D</given-names></name>, <name><surname>Bradford</surname><given-names>PA</given-names></name> (<year>2005</year>) <article-title>Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in <italic>Klebsiella pneumoniae</italic></article-title>. <source>Antimicrob Agents Chemother</source>
<volume>49</volume>: <fpage>1017</fpage>&#x02013;<lpage>1022</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/AAC.49.3.1017-1022.2005">10.1128/AAC.49.3.1017-1022.2005</ext-link></comment>
<?supplied-pmid 15728897?><pub-id pub-id-type="pmid">15728897</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref022"><label>22</label><mixed-citation publication-type="journal">
<name><surname>Podschun</surname><given-names>R</given-names></name>, <name><surname>Ullmann</surname><given-names>U</given-names></name> (<year>1998</year>) <article-title><italic>Klebsiella</italic> spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors</article-title>. <source>Clin Microbiol Rev</source>
<volume>11</volume>: <fpage>589</fpage>&#x02013;<lpage>603</lpage>.<pub-id pub-id-type="pmid">9767057</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref023"><label>23</label><mixed-citation publication-type="journal">
<name><surname>Fookes</surname><given-names>M</given-names></name>, <name><surname>Yu</surname><given-names>J</given-names></name>, <name><surname>De Majumdar</surname><given-names>S</given-names></name>, <name><surname>Thomson</surname><given-names>N</given-names></name>, <name><surname>Schneiders</surname><given-names>T</given-names></name> (<year>2013</year>) <article-title>Genome Sequence of <italic>Klebsiella pneumoniae</italic> Ecl8, a Reference Strain for Targeted Genetic Manipulation</article-title>. <source>Genome Announc</source>
<volume>1</volume>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/genomeA.00027-12">10.1128/genomeA.00027-12</ext-link></comment></mixed-citation></ref><ref id="ppat.1004627.ref024"><label>24</label><mixed-citation publication-type="journal">
<name><surname>Chinni</surname><given-names>SV</given-names></name>, <name><surname>Raabe</surname><given-names>CA</given-names></name>, <name><surname>Zakaria</surname><given-names>R</given-names></name>, <name><surname>Randau</surname><given-names>G</given-names></name>, <name><surname>Hoe</surname><given-names>CH</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Experimental identification and characterization of 97 novel npcRNA candidates in <italic>Salmonella enterica</italic> serovar Typhi</article-title>. <source>Nucleic Acids Res</source>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/nar/gkq281">10.1093/nar/gkq281</ext-link></comment></mixed-citation></ref><ref id="ppat.1004627.ref025"><label>25</label><mixed-citation publication-type="journal">
<name><surname>Yoder-Himes</surname><given-names>DR</given-names></name>, <name><surname>Chain</surname><given-names>PS</given-names></name>, <name><surname>Zhu</surname><given-names>Y</given-names></name>, <name><surname>Wurtzel</surname><given-names>O</given-names></name>, <name><surname>Rubin</surname><given-names>EM</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Mapping the <italic>Burkholderia cenocepacia</italic> niche response via high-throughput sequencing</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>106</volume>: <fpage>3976</fpage>&#x02013;<lpage>3981</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.0813403106">10.1073/pnas.0813403106</ext-link></comment>
<?supplied-pmid 19234113?><pub-id pub-id-type="pmid">19234113</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref026"><label>26</label><mixed-citation publication-type="journal">
<name><surname>Pomposiello</surname><given-names>PJ</given-names></name>, <name><surname>Demple</surname><given-names>B</given-names></name> (<year>2000</year>) <article-title>Identification of SoxS-regulated genes in <italic>Salmonella enterica</italic> serovar typhimurium</article-title>. <source>J Bacteriol</source>
<volume>182</volume>: <fpage>23</fpage>&#x02013;<lpage>29</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/JB.182.1.23-29.2000">10.1128/JB.182.1.23-29.2000</ext-link></comment>
<?supplied-pmid 10613858?><pub-id pub-id-type="pmid">10613858</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref027"><label>27</label><mixed-citation publication-type="journal">
<name><surname>Han</surname><given-names>X</given-names></name>, <name><surname>Geng</surname><given-names>J</given-names></name>, <name><surname>Zhang</surname><given-names>L</given-names></name>, <name><surname>Lu</surname><given-names>T</given-names></name> (<year>2011</year>) <article-title>The role of <italic>Escherichia coli</italic> YrbB in the lethal action of quinolones</article-title>. <source>J Antimicrob Chemother</source>
<volume>66</volume>: <fpage>323</fpage>&#x02013;<lpage>331</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/jac/dkq427">10.1093/jac/dkq427</ext-link></comment>
<?supplied-pmid 21098540?><pub-id pub-id-type="pmid">21098540</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref028"><label>28</label><mixed-citation publication-type="journal">
<name><surname>Malinverni</surname><given-names>JC</given-names></name>, <name><surname>Silhavy</surname><given-names>TJ</given-names></name> (<year>2009</year>) <article-title>An ABC transport system that maintains lipid asymmetry in the gram-negative outer membrane</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>106</volume>: <fpage>8009</fpage>&#x02013;<lpage>8014</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.0903229106">10.1073/pnas.0903229106</ext-link></comment>
<?supplied-pmid 19383799?><pub-id pub-id-type="pmid">19383799</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref029"><label>29</label><mixed-citation publication-type="journal">
<name><surname>Raetz</surname><given-names>CR</given-names></name>, <name><surname>Guan</surname><given-names>Z</given-names></name>, <name><surname>Ingram</surname><given-names>BO</given-names></name>, <name><surname>Six</surname><given-names>DA</given-names></name>, <name><surname>Song</surname><given-names>F</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Discovery of new biosynthetic pathways: the lipid A story</article-title>. <source>J Lipid Res</source>
<volume>50</volume>
<issue>Suppl</issue>: <fpage>S103</fpage>&#x02013;<lpage>108</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1194/jlr.R800060-JLR200">10.1194/jlr.R800060-JLR200</ext-link></comment>
<?supplied-pmid 18974037?><pub-id pub-id-type="pmid">18974037</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref030"><label>30</label><mixed-citation publication-type="journal">
<name><surname>Gunn</surname><given-names>JS</given-names></name> (<year>2001</year>) <article-title>Bacterial modification of LPS and resistance to antimicrobial peptides</article-title>. <source>J Endotoxin Res</source>
<volume>7</volume>: <fpage>57</fpage>&#x02013;<lpage>62</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1177/09680519010070011001">10.1177/09680519010070011001</ext-link></comment>
<?supplied-pmid 11521084?><pub-id pub-id-type="pmid">11521084</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref031"><label>31</label><mixed-citation publication-type="journal">
<name><surname>Llobet</surname><given-names>E</given-names></name>, <name><surname>Campos</surname><given-names>MA</given-names></name>, <name><surname>Gimenez</surname><given-names>P</given-names></name>, <name><surname>Moranta</surname><given-names>D</given-names></name>, <name><surname>Bengoechea</surname><given-names>JA</given-names></name> (<year>2011</year>) <article-title>Analysis of the networks controlling the antimicrobial-peptide-dependent induction of <italic>Klebsiella pneumoniae</italic> virulence factors</article-title>. <source>Infect Immun</source>
<volume>79</volume>: <fpage>3718</fpage>&#x02013;<lpage>3732</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/IAI.05226-11">10.1128/IAI.05226-11</ext-link></comment>
<?supplied-pmid 21708987?><pub-id pub-id-type="pmid">21708987</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref032"><label>32</label><mixed-citation publication-type="journal">
<name><surname>Clements</surname><given-names>A</given-names></name>, <name><surname>Tull</surname><given-names>D</given-names></name>, <name><surname>Jenney</surname><given-names>AW</given-names></name>, <name><surname>Farn</surname><given-names>JL</given-names></name>, <name><surname>Kim</surname><given-names>SH</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Secondary acylation of <italic>Klebsiella pneumoniae</italic> lipopolysaccharide contributes to sensitivity to antibacterial peptides</article-title>. <source>J Biol Chem</source>
<volume>282</volume>: <fpage>15569</fpage>&#x02013;<lpage>15577</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M701454200">10.1074/jbc.M701454200</ext-link></comment>
<?supplied-pmid 17371870?><pub-id pub-id-type="pmid">17371870</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref033"><label>33</label><mixed-citation publication-type="journal">
<name><surname>Campos</surname><given-names>MA</given-names></name>, <name><surname>Vargas</surname><given-names>MA</given-names></name>, <name><surname>Regueiro</surname><given-names>V</given-names></name>, <name><surname>Llompart</surname><given-names>CM</given-names></name>, <name><surname>Alberti</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides</article-title>. <source>Infect Immun</source>
<volume>72</volume>: <fpage>7107</fpage>&#x02013;<lpage>7114</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/IAI.72.12.7107-7114.2004">10.1128/IAI.72.12.7107-7114.2004</ext-link></comment>
<?supplied-pmid 15557634?><pub-id pub-id-type="pmid">15557634</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref034"><label>34</label><mixed-citation publication-type="journal">
<name><surname>March</surname><given-names>C</given-names></name>, <name><surname>Cano</surname><given-names>V</given-names></name>, <name><surname>Moranta</surname><given-names>D</given-names></name>, <name><surname>Llobet</surname><given-names>E</given-names></name>, <name><surname>Perez-Gutierrez</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Role of bacterial surface structures on the interaction of <italic>Klebsiella pneumoniae</italic> with phagocytes</article-title>. <source>PLoS One</source>
<volume>8</volume>: <fpage>e56847</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0056847">10.1371/journal.pone.0056847</ext-link></comment>
<?supplied-pmid 23457627?><pub-id pub-id-type="pmid">23457627</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref035"><label>35</label><mixed-citation publication-type="journal">
<name><surname>Shu</surname><given-names>HY</given-names></name>, <name><surname>Fung</surname><given-names>CP</given-names></name>, <name><surname>Liu</surname><given-names>YM</given-names></name>, <name><surname>Wu</surname><given-names>KM</given-names></name>, <name><surname>Chen</surname><given-names>YT</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Genetic diversity of capsular polysaccharide biosynthesis in <italic>Klebsiella pneumoniae</italic> clinical isolates</article-title>. <source>Microbiology</source>
<volume>155</volume>: <fpage>4170</fpage>&#x02013;<lpage>4183</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1099/mic.0.029017-0">10.1099/mic.0.029017-0</ext-link></comment>
<?supplied-pmid 19744990?><pub-id pub-id-type="pmid">19744990</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref036"><label>36</label><mixed-citation publication-type="journal">
<name><surname>Lawlor</surname><given-names>MS</given-names></name>, <name><surname>Hsu</surname><given-names>J</given-names></name>, <name><surname>Rick</surname><given-names>PD</given-names></name>, <name><surname>Miller</surname><given-names>VL</given-names></name> (<year>2005</year>) <article-title>Identification of <italic>Klebsiella pneumoniae</italic> virulence determinants using an intranasal infection model</article-title>. <source>Mol Microbiol</source>
<volume>58</volume>: <fpage>1054</fpage>&#x02013;<lpage>1073</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1365-2958.2005.04918.x">10.1111/j.1365-2958.2005.04918.x</ext-link></comment>
<?supplied-pmid 16262790?><pub-id pub-id-type="pmid">16262790</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref037"><label>37</label><mixed-citation publication-type="journal">
<name><surname>Schneiders</surname><given-names>T</given-names></name>, <name><surname>Amyes</surname><given-names>SG</given-names></name>, <name><surname>Levy</surname><given-names>SB</given-names></name> (<year>2003</year>) <article-title>Role of AcrR and <italic>ramA</italic> in fluoroquinolone resistance in clinical <italic>Klebsiella pneumoniae</italic> isolates from Singapore</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>47</volume>: <fpage>2831</fpage>&#x02013;<lpage>2837</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/AAC.47.9.2831-2837.2003">10.1128/AAC.47.9.2831-2837.2003</ext-link></comment>
<?supplied-pmid 12936981?><pub-id pub-id-type="pmid">12936981</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref038"><label>38</label><mixed-citation publication-type="journal">
<name><surname>Veleba</surname><given-names>M</given-names></name>, <name><surname>Higgins</surname><given-names>PG</given-names></name>, <name><surname>Gonzalez</surname><given-names>G</given-names></name>, <name><surname>Seifert</surname><given-names>H</given-names></name>, <name><surname>Schneiders</surname><given-names>T</given-names></name> (<year>2012</year>) <article-title>Characterization of RarA, a novel AraC family multidrug resistance regulator in <italic>Klebsiella pneumoniae</italic></article-title>. <source>Antimicrob Agents Chemother</source>
<volume>56</volume>: <fpage>4450</fpage>&#x02013;<lpage>4458</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/AAC.00456-12">10.1128/AAC.00456-12</ext-link></comment>
<?supplied-pmid 22644028?><pub-id pub-id-type="pmid">22644028</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref039"><label>39</label><mixed-citation publication-type="journal">
<name><surname>Martin</surname><given-names>RG</given-names></name>, <name><surname>Gillette</surname><given-names>WK</given-names></name>, <name><surname>Rhee</surname><given-names>S</given-names></name>, <name><surname>Rosner</surname><given-names>JL</given-names></name> (<year>1999</year>) <article-title>Structural requirements for marbox function in transcriptional activation of <italic>mar</italic>/<italic>sox</italic>/<italic>rob</italic> regulon promoters in <italic>Escherichia coli</italic>: sequence, orientation and spatial relationship to the core promoter</article-title>. <source>Mol Microbiol</source>
<volume>34</volume>: <fpage>431</fpage>&#x02013;<lpage>441</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1046/j.1365-2958.1999.01599.x">10.1046/j.1365-2958.1999.01599.x</ext-link></comment>
<?supplied-pmid 10564485?><pub-id pub-id-type="pmid">10564485</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref040"><label>40</label><mixed-citation publication-type="journal">
<name><surname>Martin</surname><given-names>RG</given-names></name>, <name><surname>Gillette</surname><given-names>WK</given-names></name>, <name><surname>Rosner</surname><given-names>JL</given-names></name> (<year>2000</year>) <article-title>Promoter discrimination by the related transcriptional activators MarA and SoxS: differential regulation by differential binding</article-title>. <source>Mol Microbiol</source>
<volume>35</volume>: <fpage>623</fpage>&#x02013;<lpage>634</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1046/j.1365-2958.2000.01732.x">10.1046/j.1365-2958.2000.01732.x</ext-link></comment>
<?supplied-pmid 10672184?><pub-id pub-id-type="pmid">10672184</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref041"><label>41</label><mixed-citation publication-type="journal">
<name><surname>Ricci</surname><given-names>V</given-names></name>, <name><surname>Tzakas</surname><given-names>P</given-names></name>, <name><surname>Buckley</surname><given-names>A</given-names></name>, <name><surname>Piddock</surname><given-names>LJ</given-names></name> (<year>2006</year>) <article-title>Ciprofloxacin-resistant <italic>Salmonella enterica</italic> serovar Typhimurium strains are difficult to select in the absence of AcrB and TolC</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>50</volume>: <fpage>38</fpage>&#x02013;<lpage>42</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/AAC.50.1.38-42.2006">10.1128/AAC.50.1.38-42.2006</ext-link></comment>
<?supplied-pmid 16377664?><pub-id pub-id-type="pmid">16377664</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref042"><label>42</label><mixed-citation publication-type="journal">
<name><surname>Hobbs</surname><given-names>EC</given-names></name>, <name><surname>Yin</surname><given-names>X</given-names></name>, <name><surname>Paul</surname><given-names>BJ</given-names></name>, <name><surname>Astarita</surname><given-names>JL</given-names></name>, <name><surname>Storz</surname><given-names>G</given-names></name> (<year>2012</year>) <article-title>Conserved small protein associates with the multidrug efflux pump AcrB and differentially affects antibiotic resistance</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>109</volume>: <fpage>16696</fpage>&#x02013;<lpage>16701</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1210093109">10.1073/pnas.1210093109</ext-link></comment>
<?supplied-pmid 23010927?><pub-id pub-id-type="pmid">23010927</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref043"><label>43</label><mixed-citation publication-type="journal">
<name><surname>Padilla</surname><given-names>E</given-names></name>, <name><surname>Llobet</surname><given-names>E</given-names></name>, <name><surname>Domenech-Sanchez</surname><given-names>A</given-names></name>, <name><surname>Martinez-Martinez</surname><given-names>L</given-names></name>, <name><surname>Bengoechea</surname><given-names>JA</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title><italic>Klebsiella pneumoniae</italic> AcrAB efflux pump contributes to antimicrobial resistance and virulence</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>54</volume>: <fpage>177</fpage>&#x02013;<lpage>183</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/AAC.00715-09">10.1128/AAC.00715-09</ext-link></comment>
<?supplied-pmid 19858254?><pub-id pub-id-type="pmid">19858254</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref044"><label>44</label><mixed-citation publication-type="journal">
<name><surname>Raetz</surname><given-names>CR</given-names></name>, <name><surname>Reynolds</surname><given-names>CM</given-names></name>, <name><surname>Trent</surname><given-names>MS</given-names></name>, <name><surname>Bishop</surname><given-names>RE</given-names></name> (<year>2007</year>) <article-title>Lipid A modification systems in gram-negative bacteria</article-title>. <source>Annu Rev Biochem</source>
<volume>76</volume>: <fpage>295</fpage>&#x02013;<lpage>329</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1146/annurev.biochem.76.010307.145803">10.1146/annurev.biochem.76.010307.145803</ext-link></comment>
<?supplied-pmid 17362200?><pub-id pub-id-type="pmid">17362200</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref045"><label>45</label><mixed-citation publication-type="journal">
<name><surname>Velkov</surname><given-names>T</given-names></name>, <name><surname>Soon</surname><given-names>RL</given-names></name>, <name><surname>Chong</surname><given-names>PL</given-names></name>, <name><surname>Huang</surname><given-names>JX</given-names></name>, <name><surname>Cooper</surname><given-names>MA</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Molecular basis for the increased polymyxin susceptibility of <italic>Klebsiella pneumoniae</italic> strains with under-acylated lipid A</article-title>. <source>Innate Immun</source>
<volume>19</volume>: <fpage>265</fpage>&#x02013;<lpage>277</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1177/1753425912459092">10.1177/1753425912459092</ext-link></comment>
<?supplied-pmid 23008349?><pub-id pub-id-type="pmid">23008349</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref046"><label>46</label><mixed-citation publication-type="journal">
<name><surname>Needham</surname><given-names>BD</given-names></name>, <name><surname>Trent</surname><given-names>MS</given-names></name> (<year>2013</year>) <article-title>Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis</article-title>. <source>Nat Rev Microbiol</source>
<volume>11</volume>: <fpage>467</fpage>&#x02013;<lpage>481</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrmicro3047">10.1038/nrmicro3047</ext-link></comment>
<?supplied-pmid 23748343?><pub-id pub-id-type="pmid">23748343</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref047"><label>47</label><mixed-citation publication-type="journal">
<name><surname>Gunn</surname><given-names>JS</given-names></name>, <name><surname>Ryan</surname><given-names>SS</given-names></name>, <name><surname>Van Velkinburgh</surname><given-names>JC</given-names></name>, <name><surname>Ernst</surname><given-names>RK</given-names></name>, <name><surname>Miller</surname><given-names>SI</given-names></name> (<year>2000</year>) <article-title>Genetic and functional analysis of a PmrA-PmrB-regulated locus necessary for lipopolysaccharide modification, antimicrobial peptide resistance, and oral virulence of <italic>Salmonella enterica</italic> serovar typhimurium</article-title>. <source>Infect Immun</source>
<volume>68</volume>: <fpage>6139</fpage>&#x02013;<lpage>6146</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/IAI.68.11.6139-6146.2000">10.1128/IAI.68.11.6139-6146.2000</ext-link></comment>
<?supplied-pmid 11035717?><pub-id pub-id-type="pmid">11035717</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref048"><label>48</label><mixed-citation publication-type="journal">
<name><surname>Buckley</surname><given-names>AM</given-names></name>, <name><surname>Webber</surname><given-names>MA</given-names></name>, <name><surname>Cooles</surname><given-names>S</given-names></name>, <name><surname>Randall</surname><given-names>LP</given-names></name>, <name><surname>La Ragione</surname><given-names>RM</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>The AcrAB-TolC efflux system of <italic>Salmonella enterica</italic> serovar Typhimurium plays a role in pathogenesis</article-title>. <source>Cell Microbiol</source>
<volume>8</volume>: <fpage>847</fpage>&#x02013;<lpage>856</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1462-5822.2005.00671.x">10.1111/j.1462-5822.2005.00671.x</ext-link></comment>
<?supplied-pmid 16611233?><pub-id pub-id-type="pmid">16611233</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref049"><label>49</label><mixed-citation publication-type="journal">
<name><surname>Mdluli</surname><given-names>KE</given-names></name>, <name><surname>Witte</surname><given-names>PR</given-names></name>, <name><surname>Kline</surname><given-names>T</given-names></name>, <name><surname>Barb</surname><given-names>AW</given-names></name>, <name><surname>Erwin</surname><given-names>AL</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Molecular validation of LpxC as an antibacterial drug target in <italic>Pseudomonas aeruginosa</italic></article-title>. <source>Antimicrob Agents Chemother</source>
<volume>50</volume>: <fpage>2178</fpage>&#x02013;<lpage>2184</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/AAC.00140-06">10.1128/AAC.00140-06</ext-link></comment>
<?supplied-pmid 16723580?><pub-id pub-id-type="pmid">16723580</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref050"><label>50</label><mixed-citation publication-type="journal">
<name><surname>Moreira</surname><given-names>CG</given-names></name>, <name><surname>Herrera</surname><given-names>CM</given-names></name>, <name><surname>Needham</surname><given-names>BD</given-names></name>, <name><surname>Parker</surname><given-names>CT</given-names></name>, <name><surname>Libby</surname><given-names>SJ</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Virulence and stress-related periplasmic protein (VisP) in bacterial/host associations</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>110</volume>: <fpage>1470</fpage>&#x02013;<lpage>1475</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1215416110">10.1073/pnas.1215416110</ext-link></comment>
<?supplied-pmid 23302685?><pub-id pub-id-type="pmid">23302685</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref051"><label>51</label><mixed-citation publication-type="journal">
<name><surname>Moranta</surname><given-names>D</given-names></name>, <name><surname>Regueiro</surname><given-names>V</given-names></name>, <name><surname>March</surname><given-names>C</given-names></name>, <name><surname>Llobet</surname><given-names>E</given-names></name>, <name><surname>Margareto</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title><italic>Klebsiella pneumoniae</italic> capsule polysaccharide impedes the expression of beta-defensins by airway epithelial cells</article-title>. <source>Infect Immun</source>
<volume>78</volume>: <fpage>1135</fpage>&#x02013;<lpage>1146</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/IAI.00940-09">10.1128/IAI.00940-09</ext-link></comment>
<?supplied-pmid 20008534?><pub-id pub-id-type="pmid">20008534</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref052"><label>52</label><mixed-citation publication-type="journal">
<name><surname>Croucher</surname><given-names>NJ</given-names></name>, <name><surname>Fookes</surname><given-names>MC</given-names></name>, <name><surname>Perkins</surname><given-names>TT</given-names></name>, <name><surname>Turner</surname><given-names>DJ</given-names></name>, <name><surname>Marguerat</surname><given-names>SB</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>A simple method for directional transcriptome sequencing using Illumina technology</article-title>. <source>Nucleic Acids Res</source>
<volume>37</volume>: <fpage>e148</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/nar/gkp811">10.1093/nar/gkp811</ext-link></comment>
<?supplied-pmid 19815668?><pub-id pub-id-type="pmid">19815668</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref053"><label>53</label><mixed-citation publication-type="journal">
<name><surname>Quail</surname><given-names>MA</given-names></name>, <name><surname>Kozarewa</surname><given-names>I</given-names></name>, <name><surname>Smith</surname><given-names>F</given-names></name>, <name><surname>Scally</surname><given-names>A</given-names></name>, <name><surname>Stephens</surname><given-names>PJ</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>A large genome center&#x02019;s improvements to the Illumina sequencing system</article-title>. <source>Nat Methods</source>
<volume>5</volume>: <fpage>1005</fpage>&#x02013;<lpage>1010</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nmeth.1270">10.1038/nmeth.1270</ext-link></comment>
<?supplied-pmid 19034268?><pub-id pub-id-type="pmid">19034268</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref054"><label>54</label><mixed-citation publication-type="journal">
<name><surname>Briggs</surname><given-names>GS</given-names></name>, <name><surname>Mahdi</surname><given-names>AA</given-names></name>, <name><surname>Wen</surname><given-names>Q</given-names></name>, <name><surname>Lloyd</surname><given-names>RG</given-names></name> (<year>2005</year>) <article-title>DNA binding by the substrate specificity (wedge) domain of RecG helicase suggests a role in processivity</article-title>. <source>J Biol Chem</source>
<volume>280</volume>: <fpage>13921</fpage>&#x02013;<lpage>13927</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M412054200">10.1074/jbc.M412054200</ext-link></comment>
<?supplied-pmid 15695524?><pub-id pub-id-type="pmid">15695524</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref055"><label>55</label><mixed-citation publication-type="journal">
<name><surname>Schneiders</surname><given-names>T</given-names></name>, <name><surname>Levy</surname><given-names>SB</given-names></name> (<year>2006</year>) <article-title>MarA-mediated transcriptional repression of the <italic>rob</italic> promoter</article-title>. <source>J Biol Chem</source>
<volume>281</volume>: <fpage>10049</fpage>&#x02013;<lpage>10055</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M512097200">10.1074/jbc.M512097200</ext-link></comment>
<?supplied-pmid 16478729?><pub-id pub-id-type="pmid">16478729</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref056"><label>56</label><mixed-citation publication-type="journal">
<name><surname>Barbosa</surname><given-names>TM</given-names></name>, <name><surname>Levy</surname><given-names>SB</given-names></name> (<year>2002</year>) <article-title>Activation of the <italic>Escherichia coli nfnB</italic> gene by MarA through a highly divergent marbox in a class II promoter</article-title>. <source>Mol Microbiol</source>
<volume>45</volume>: <fpage>191</fpage>&#x02013;<lpage>202</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1046/j.1365-2958.2002.03006.x">10.1046/j.1365-2958.2002.03006.x</ext-link></comment>
<?supplied-pmid 12100559?><pub-id pub-id-type="pmid">12100559</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref057"><label>57</label><mixed-citation publication-type="journal">
<name><surname>Cano</surname><given-names>V</given-names></name>, <name><surname>Moranta</surname><given-names>D</given-names></name>, <name><surname>Llobet-Brossa</surname><given-names>E</given-names></name>, <name><surname>Bengoechea</surname><given-names>JA</given-names></name>, <name><surname>Garmendia</surname><given-names>J</given-names></name> (<year>2009</year>) <article-title><italic>Klebsiella pneumoniae</italic> triggers a cytotoxic effect on airway epithelial cells</article-title>. <source>BMC Microbiol</source>
<volume>9</volume>: <fpage>156</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1471-2180-9-156">10.1186/1471-2180-9-156</ext-link></comment>
<?supplied-pmid 19650888?><pub-id pub-id-type="pmid">19650888</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref058"><label>58</label><mixed-citation publication-type="journal">
<name><surname>Regueiro</surname><given-names>V</given-names></name>, <name><surname>Campos</surname><given-names>MA</given-names></name>, <name><surname>Pons</surname><given-names>J</given-names></name>, <name><surname>Alberti</surname><given-names>S</given-names></name>, <name><surname>Bengoechea</surname><given-names>JA</given-names></name> (<year>2006</year>) <article-title>The uptake of a <italic>Klebsiella pneumoniae</italic> capsule polysaccharide mutant triggers an inflammatory response by human airway epithelial cells</article-title>. <source>Microbiology</source>
<volume>152</volume>: <fpage>555</fpage>&#x02013;<lpage>566</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1099/mic.0.28285-0">10.1099/mic.0.28285-0</ext-link></comment>
<?supplied-pmid 16436443?><pub-id pub-id-type="pmid">16436443</pub-id></mixed-citation></ref><ref id="ppat.1004627.ref059"><label>59</label><mixed-citation publication-type="journal">
<name><surname>George</surname><given-names>AM</given-names></name>, <name><surname>Hall</surname><given-names>RM</given-names></name>, <name><surname>Stokes</surname><given-names>HW</given-names></name> (<year>1995</year>) <article-title>Multidrug resistance in <italic>Klebsiella pneumoniae</italic>: a novel gene, <italic>ramA</italic>, confers a multidrug resistance phenotype in <italic>Escherichia coli</italic></article-title>. <source>Microbiology</source>
<volume>141</volume>: <fpage>1909</fpage>&#x02013;<lpage>1920</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1099/13500872-141-8-1909">10.1099/13500872-141-8-1909</ext-link></comment>
<?supplied-pmid 7551053?><pub-id pub-id-type="pmid">7551053</pub-id></mixed-citation></ref></ref-list></back></article>